<SEC-DOCUMENT>0001193125-15-123467.txt : 20150409
<SEC-HEADER>0001193125-15-123467.hdr.sgml : 20150409
<ACCEPTANCE-DATETIME>20150409070331
ACCESSION NUMBER:		0001193125-15-123467
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20150409
FILED AS OF DATE:		20150409
DATE AS OF CHANGE:		20150409

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVOGEN LTD
		CENTRAL INDEX KEY:			0001075880
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-29962
		FILM NUMBER:		15760345

	BUSINESS ADDRESS:	
		STREET 1:		LEVEL 1
		STREET 2:		16 - 20  EDGEWORTH DAVID AVE
		CITY:			HORNSBY NSW
		STATE:			C3
		ZIP:			2077
		BUSINESS PHONE:		01161298780088

	MAIL ADDRESS:	
		STREET 1:		LEVEL 1
		STREET 2:		16 - 20  EDGEWORTH DAVID AVE
		CITY:			HORNSBY NSW
		STATE:			C3
		ZIP:			2077
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d907623d6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Form 6-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF FOREIGN PRIVATE ISSUER </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the month of April, 2015 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Novogen
Limited </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#146;s name into English) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>16-20 Edgeworth David Ave, Hornsby, NSW 2077, Australia </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form 20-F&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Form 40-F&nbsp;&nbsp; <FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note</B>: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted
solely to provide an attached annual report to security holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(7):&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note</B>: Regulation S-T Rule 101(b)(7) only
permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated,
domiciled or legally organized (the registrant&#146;s &#147;home country&#148;), or under the rules of the home country exchange on which the registrant&#146;s securities are traded, as long as the report or other document is not a press release, is
not required to be and has not been distributed to the registrant&#146;s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission
pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;&nbsp;&nbsp; No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If &#147;yes&#148; is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b) </P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Novogen Limited </B>(Registrant) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Lionel Mateo </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lionel Mateo </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Company Secretary </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date 09&nbsp;April 2015 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g907623g68q31.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="55%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ASX:NRT</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NASDAQ:NVGN</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novogen Ltd</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Company)</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ABN 37 063 259 754</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Capital Structure</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ordinary Shares on issue:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">260 M</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board of
Directors</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dr Graham Kelly</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chairman &amp; Executive Director</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Steve Coffey</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Non Executive Director</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>John O&#146;Connor</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Non Executive Director</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prof Peter Gunning</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Non Executive Director</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ASX RELEASE</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9 April 2015</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AUSTRALIAN STUDIES CONFIRM ANISINA AS POTENTIAL IMPORTANT NEW WEAPON
AGAINST MELANOMA</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&nbsp;&nbsp;&nbsp;&nbsp;<B>Anisina kills melanoma cells regardless of their mutation status</B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&nbsp;&nbsp;&nbsp;&nbsp;<B>Melanoma cells
with normal and mutated BRAF gene killed by Anisina</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&nbsp;&nbsp;&nbsp;&nbsp;<B>Anisina to come into the clinic as a new weapon against melanoma</B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sydney, Australia, 9 April 2015:</B> US-Australian drug discovery company, Novogen
(NRT:ASX; NVGN: NASDAQ), today announced that studies conducted at The University of Queensland Diamantina Institute (UQDI) revealed that experimental drug, Anisina, killed melanoma cells irrespective of their mutational status.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The significance of this finding lies in the fact that melanoma is associated with a
variety of mutations, with those to the BRAF gene being the most prominent. A mutation to the BRAF gene occurs in about half of all melanoma patients and two drugs that target that mutation (vemurafenib and dabrafenib) have come to market in recent
times. No targeted therapy exists for the 50% of melanoma patients whose tumors do not have the BRAF mutation. But even where a response is obtained with a BRAF-inhibitor, resistance typically develops within a year of treatment. Therefore the
development of a drug that kills melanoma cells irrespective of their BRAF or any other mutational status has become an urgent clinical imperative.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novogen believes that Anisina represents a significant potential opportunity to meet this need.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UQDI screened Anisina against a panel of melanoma cells obtained from patients and which
represented the spectrum of mutations (BRAF, NRAS and c-KIT) commonly found in the community. Anisina was uniformly cytotoxic to the panel of cells, regardless of their mutational status. Importantly, Anisina showed a high level of specificity to
cancer cells, with toxicity against normal melanocytes requiring a four-fold drug level.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Anisina is an anti-tropomyosin compound that targets the cytoskeleton of the cancer cells. It is being brought into the clinic for the treatment of cancers as
a companion drug for the anti-mitotic family of drugs&#133;the taxanes and vinca alkaloids. The rationale is that the use of Anisina (targeting the microfilaments) in combination with anti-mitotic drugs (targeting the microtubules), provide
comprehensive destruction of the two key parts of the cancer cell&#146;s skeleton resulting in a 20-fold increase in the anti-cancer effect of either drug family alone.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Anisina is being brought into the clinic in early-2016 for the treatment of solid cancers, with late-stage melanoma and prostate cancer in adults and
neuroblastoma in children being three key target indications. The current results give strength to the aim of conducting a clinical study in patients with late-stage melanoma using a combined treatment of Anisina and vincristine.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Nikolas Haass MD PhD and Brian Gabrielli PhD conducted the research studies.</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g907623g31b33.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g907623g80l95.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr Haass said, &#147;These findings from the preliminary screen with Anisina are exciting. Finding a compound that is
equally effective against a wide panel of melanoma cell types irrespective of the genetic background has been a long-held goal. The University of Queensland Diamantina Institute is pleased to be part of the effort to bring this new drug candidate
into the clinic.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Justine Stehn PhD, Novogen Anti-Tropomyosin Program Director, said, &#147;Melanoma is a notoriously difficult cancer to treat. The
standard first-line cytotoxic drugs such as the taxanes and vinca alkaloids have little anti-cancer effect.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;But we see a 20-fold increase in
the cancer killing effect of these drugs when combined with Anisina. We have demonstrated this combination effect with vincristine in prostate cancer cells, neuroblastoma cells, and now melanoma cells. The idea that we now have a means of making
melanoma cells respond to potent anti-cancer drugs such as vincristine is an exciting development for patients with melanoma.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Graham Kelly PhD,
Novogen Group CEO, said, &#147;These results support our belief that Anisina has the potential to become one of the most widely used anti-cancer drugs across the full spectrum of cancer. In conjunction with our clinical advisors, we have a clinical
strategy laid out which we intend to prosecute all the way through to achieving regulatory approval.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Melanoma </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The incidence of melanoma has doubled since 1973 and continues to increase, with countries such as Australia and New Zealand taking the lead with one of the
highest rates of morbidity and mortality of melanoma. Around 12,500 new cases are diagnosed each year in Australia with malignant melanoma and it is responsible for over 1,500 deaths. In the US, approximately 74,000 thousand cases of invasive
melanoma are expected to be diagnosed, with 10,000 deaths. In the UK, malignant melanoma is the 5th most common cancer. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are limited therapeutic
options for the treatment of metastatic melanoma as standard of care chemotherapy is ineffective against this highly resistant disease. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Melanomas are now
&#147;molecularly classified&#148; based on the activating mutations in the MAP kinase pathway. The most frequent mutations are activating oncogenic mutations in the BRAF gene. These mutations are present in 40-60% of malignant melanoma. There is a
smaller subset of less common activating mutations which include: <I>NRAS</I>, which is found in approximately 15-20% of melanomas; <I>c-KIT</I> mutations, make up a smaller percentage of the mutation found in melanoma among the white population
(6-7%) but are the most common mutation found in the Asian population; and <I>CDK4</I>&nbsp;mutations which have been identified in in approximately 4% of melanomas. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Despite remarkable clinical responses to targeted therapies and to immunotherapies, relapse of the disease is common in the vast majority of patients. In
addition, selectivity of these targeted inhibitors leaves greater than 50% of patients with inadequate treatment options. Therefore it is a clinical imperative that new therapeutic strategies be developed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Anisina </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Anisina is a small molecule that belongs
to a class of compounds known as anti-tropomyosins which target and destroy the microfilaments of cancer cells. Anisina binds to and inhibits the function of a core component of the microfilaments, tropomyosin Tpm3.1 (previously known as Tm5NM1).
The role of Tpm 3.1 is to protect and stabilise the microfilaments of a cell. Inhibition of this protein by Anisina leads to the disassembly and collapse of the microfilaments resulting in cell death. Despite the target protein, Tpm3.1 being found
in both normal and cancer cells, Anisina is significantly more effective against cancer cells as these cells rely more heavily on a functional Tpm3.1 for survival. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g907623g31b33.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g907623g80l95.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Anti-Mitotic Drugs </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Anti-mitotic drugs are drugs that block cell division (mitosis) by targeting the microtubule component of a cell&#146;s cytoskeleton. Anti-microtubule drugs
are the taxanes (paclitaxel, docetaxel, abraxane) and vinca alkaloids (vincristine, vinblastine and vinorelbine). These drugs remain among the most widely prescribed anti-cancer drugs after 35 years of use. Anti-mitotic drugs are standard of care
for breast, prostate, lung, ovarian, colo-rectal, gastric and head and neck cancer, and many forms of leukaemia. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About The University of Queensland
Diamantina Institute </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UQDI is a modern research facility where clinical and basic science converge in the translational research of cancer, immunology
and genomic medicine. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UQDI is host to more than 300 researchers, students and support staff. It lays claim to global, world-changing discoveries such as
the world&#146;s first cervical cancer vaccine. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based at the Translational Research Institute (TRI) beside the Princess Alexandra Hospital, UQDI has
strong clinical interactions and world-class facilities that enable researchers to be at the forefront of their fields. UQDI&#146;s position within the TRI allows for a collaborative research environment, enabling researchers to focus their efforts
on turning their scientific discoveries into better treatments for diseases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Novogen Limited </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novogen is a public, Australian-US drug-development company whose shares trade on both the Australian Securities Exchange (&#145;NRT&#146;) and NASDAQ
(&#145;NVGN&#146;). The Novogen group includes US-based, CanTx Inc, a joint venture company with Yale University. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novogen has two main drug technology
platforms: super-benzopyrans (SBPs) and anti-tropomyosins (ATMs). SBP compounds have been designed to kill the full heterogeneity of cells within a tumor, but with particular activity against the cancer stem (tumor-initiating) cell. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The ATM compounds target the micro-filament component of the cancer cell&#146;s cytoskeleton and have been designed to combine with anti-microtubule drugs
(taxanes, vinca alkaloids) to produce comprehensive and fatal destruction of the cancer cell cytoskeleton. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company pipeline comprises two SBP drug
candidates (TRXE-002, TRXE-009) and one ATM drug candidate (Anisina). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further information is available on our websites <U>www.novogen.com</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information please contact: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Contact</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr. Graham Kelly</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Chairman &amp; CEO</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novogen Group</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Graham.Kelly@novogen.com</U></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">+61 (0) 2 9472 4100</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Enquiries</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cristyn Humphreys</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Operating Officer</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novogen Group</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Cristyn.Humphreys@novogen.com</U></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">+61 (0) 2 9472
4111</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g907623g31b33.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g907623g80l95.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>To the extent that statements contained in this press release are not descriptions of historical facts regarding Anisina, they are forward-looking
statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as &#147;may,&#148; &#147;will,&#148; &#147;expect,&#148;
&#147;anticipate,&#148; &#147;estimate,&#148; &#147;intend,&#148; and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Examples of
forward-looking statements contained in this release include, among others, statements regarding the safety, efficacy and therapeutic potential of Anisina, the availability of data from clinical studies and our expectations regarding our research
and development programs, expanding our pipeline and advancing our two drug technology platforms. Forward-looking statements in this release involve substantial risks and uncertainties that could cause our clinical development programs, future
results, working capital performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the uncertainties inherent in the conduct of future
clinical studies, enrolment in clinical studies, availability of data from ongoing clinical studies and other matters that could affect the commercial potential of our drug candidates. Novogen undertakes no obligation to update or revise any
forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Novogen in general,
the reader is referred to filings made the U.S. Securities and Exchange Commission. </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g907623g31b33.jpg" ALT="LOGO">
 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g907623g31b33.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g907623g31b33.jpg
M_]C_X03817AI9@``34T`*@````@`!P$2``,````!``$```$:``4````!````
M8@$;``4````!````:@$H``,````!``(```$Q``(````>````<@$R``(````4
M````D(=I``0````!````I````-``"OR````G$``*_(```"<0061O8F4@4&AO
M=&]S:&]P($-3-B`H5VEN9&]W<RD`,C`Q-3HP,SHP-B`Q,SHU-CHS.0```Z`!
M``,````!``$``*`"``0````!```"RZ`#``0````!````/0`````````&`0,`
M`P````$`!@```1H`!0````$```$>`1L`!0````$```$F`2@``P````$``@``
M`@$`!`````$```$N`@(`!`````$```.B`````````$@````!````2`````'_
MV/_M``Q!9&]B95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)
M#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`#@"@`P$B``(1
M`0,1`?_=``0`"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$`
M`04!`0$!`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!
M``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U
M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#
M(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F
M-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`],),G4\J+[65M+['AC!R
MYQ@*1Y/Q5?-]`XY&3(JD21,S^;]#W)*-UHCMZMAL:2VW41!<'!NI_>A#=E7V
MM#FV0TZ@LT!']8(.SI>TEC_"`>>?Y358;MV-V_1C3X?-.T8_6=Z']UKDV_O.
M/]H_WIM[_P!YW^<?[U8/I]X^7^Q0(K_>^]);2-MUS/HV.'S)'XJQCY%]E@8[
M4$'42.$`;>T?+E&PW%UXEI;`/TH\/Y+G)%,;L;MP-?()/XJ<GQ*9)-95Y/B4
MQ)CDI))*8R[Q*!D&0TDD1/<C^*.YSA(#"?,D`?\`?G*IE.K(:,AD"3L+7:_R
MNR(1(Z-:UT/_`$;B!&NTF)4=[_WW?YQ_O1'5XY$LM(\GM/\`U3$(B#$@^8F/
MQA.83:G%SA#G.(\R?[U&NNMMK7N+W-:=6;W%IT_=>5-C6N/N<&#X$_D1FLPQ
M]*PD^0(_@DBA8NOJGP\JO)-C:2X&H@.#I$?2B/\`-5QLR)).H5'IOV$&\8DN
M?N'K%TS/NV_3#6_O_05X<CXA-.^C/&Z'%5^#_]G_[0SV4&AO=&]S:&]P(#,N
M,``X0DE-!"4``````!``````````````````````.$))300Z``````$7````
M$`````$```````MP<FEN=$]U='!U=`````4`````4'-T4V)O;VP!`````$EN
M=&5E;G5M`````$EN=&4`````0VQR;0````]P<FEN=%-I>'1E96Y":71B;V]L
M``````MP<FEN=&5R3F%M951%6%0````:`%P`7`!3`$X`1P!&`$(`50`M`$T`
M5P!3`"T`1@!0`#$`,`!<`&(`<P!I`%\`<`!R`#,```````]P<FEN=%!R;V]F
M4V5T=7!/8FIC````#`!0`'(`;P!O`&8`(`!3`&4`=`!U`'````````IP<F]O
M9E-E='5P`````0````!";'1N96YU;0````QB=6EL=&EN4')O;V8````)<')O
M;V9#35E+`#A"24T$.P`````"+0```!`````!```````2<')I;G1/=71P=71/
M<'1I;VYS````%P````!#<'1N8F]O;```````0VQB<F)O;VP``````%)G<TUB
M;V]L``````!#<FY#8F]O;```````0VYT0V)O;VP``````$QB;'-B;V]L````
M``!.9W1V8F]O;```````16UL1&)O;VP``````$EN=')B;V]L``````!"8VMG
M3V)J8P````$```````!21T)#`````P````!29"`@9&]U8D!OX```````````
M`$=R;B!D;W5B0&_@````````````0FP@(&1O=6)`;^````````````!"<F14
M56YT1B-2;'0```````````````!";&0@56YT1B-2;'0```````````````!2
M<VQT56YT1B-0>&Q`4@````````````IV96-T;W)$871A8F]O;`$`````4&=0
M<V5N=6T`````4&=0<P````!09U!#`````$QE9G15;G1&(U)L=```````````
M`````%1O<"!5;G1&(U)L=````````````````%-C;"!5;G1&(U!R8T!9````
M````````$&-R;W!7:&5N4')I;G1I;F=B;V]L``````YC<F]P4F5C=$)O='1O
M;6QO;F<`````````#&-R;W!296-T3&5F=&QO;F<`````````#6-R;W!296-T
M4FEG:'1L;VYG``````````MC<F]P4F5C=%1O<&QO;F<``````#A"24T#[0``
M````$`!(`````0`"`$@````!``(X0DE-!"8```````X`````````````/X``
M`#A"24T$#0``````!````'@X0DE-!!D```````0````>.$))30/S```````)
M```````````!`#A"24TG$```````"@`!``````````(X0DE-`_4``````$@`
M+V9F``$`;&9F``8```````$`+V9F``$`H9F:``8```````$`,@````$`6@``
M``8```````$`-0````$`+0````8```````$X0DE-`_@``````'```/______
M______________________\#Z`````#_____________________________
M`^@`````_____________________________P/H`````/______________
M______________\#Z```.$))300````````"``$X0DE-!`(```````0`````
M.$))300P```````"`0$X0DE-!"T```````8``0````(X0DE-!`@``````!``
M```!```"0````D``````.$))300>```````$`````#A"24T$&@`````#.P``
M``8``````````````#T```++`````P`P`#``,@````$`````````````````
M`````````0`````````````"RP```#T``````````````````````0``````
M```````````````````0`````0```````&YU;&P````"````!F)O=6YD<T]B
M:F,````!````````4F-T,0````0`````5&]P(&QO;F<``````````$QE9G1L
M;VYG``````````!"=&]M;&]N9P```#T`````4F=H=&QO;F<```++````!G-L
M:6-E<U9L3',````!3V)J8P````$```````5S;&EC90```!(````'<VQI8V5)
M1&QO;F<`````````!V=R;W5P241L;VYG``````````9O<FEG:6YE;G5M````
M#$53;&EC94]R:6=I;@````UA=71O1V5N97)A=&5D`````%1Y<&5E;G5M````
M"D53;&EC951Y<&4`````26UG(`````9B;W5N9'-/8FIC`````0```````%)C
M=#$````$`````%1O<"!L;VYG``````````!,969T;&]N9P``````````0G1O
M;6QO;F<````]`````%)G:'1L;VYG```"RP````-U<FQ415A4`````0``````
M`&YU;&Q415A4`````0```````$US9V5415A4`````0``````!F%L=%1A9U1%
M6%0````!```````.8V5L;%1E>'1)<TA434QB;V]L`0````AC96QL5&5X=%1%
M6%0````!```````):&]R>D%L:6=N96YU;0````]%4VQI8V5(;W)Z06QI9VX`
M```'9&5F875L=`````EV97)T06QI9VYE;G5M````#T53;&EC959E<G1!;&EG
M;@````=D969A=6QT````"V)G0V]L;W)4>7!E96YU;0```!%%4VQI8V5"1T-O
M;&]R5'EP90````!.;VYE````"71O<$]U='-E=&QO;F<`````````"FQE9G1/
M=71S971L;VYG``````````QB;W1T;VU/=71S971L;VYG``````````MR:6=H
M=$]U='-E=&QO;F<``````#A"24T$*```````#`````(_\````````#A"24T$
M%```````!`````(X0DE-!`P``````[X````!````H`````X```'@```:0```
M`Z(`&``!_]C_[0`,061O8F5?0TT``?_N``Y!9&]B90!D@`````'_VP"$``P(
M"`@)"`P)"0P1"PH+$14/#`P/%1@3$Q43$Q@1#`P,#`P,$0P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P!#0L+#0X-$`X.$!0.#@X4%`X.#@X4$0P,#`P,
M$1$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(``X`
MH`,!(@`"$0$#$0'_W0`$``K_Q`$_```!!0$!`0$!`0`````````#``$"!`4&
M!P@)"@L!``$%`0$!`0$!``````````$``@,$!08'"`D*"Q```00!`P($`@4'
M!@@%`PPS`0`"$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R62
M4_#A\6-S-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3T
MI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0`"`@$"!`0#!`4&!P<&
M!34!``(1`R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E
M!A:BLH,')C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E
M]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_V@`,`P$``A$#$0`_`/3"3)U/*B^U
ME;2^QX8P<N<8"D>3\57S?0..1DR*I$D3,_F_0]R2C=:([>K8;&DMMU$07!P;
MJ?WH0W95]K0YMD-.H+-`1_6"#LZ7M)8_P@'GG^4U6&[=C=OT8T^'S3M&/UG>
MA_=:Y-O[SC_:/]Z;>_\`>=_G'^]6#Z?>/E_L4"*_WOO26TC;=<SZ-CA\R1^*
ML8^1?98&.U!!U$CA`&WM'RY1L-Q=>):6P#]*/#^2YR13&[&[<#7R"3^*G)\2
MF2365>3XE,28Y*222F,N\2@9!D-))$3W(_BCN<X2`PGS)`'_`'YRJ93JR&C(
M9`D["UVO\KLB$2.C6M=#_P!&X@1KM)B5'>_]]W^<?[T1U>.1++2/)[3_`-4Q
M"(@Q(/F)C\83F$VIQ<X0YSB/,G^]1KKK;:U[B]S6G5F]Q:=/W7E38UKC[G!@
M^!/Y$9K,,?2L)/D"/X)(H6+KZI\/*KR38VDN!J(#@Z1'THC_`#5<;,B23J%1
MZ;]A!O&)+G[AZQ=,S[MOTPUO[_T%>'(^(33OHSQNAQ5?@__9.$))300A````
M``!5`````0$````/`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P````
M$P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`<``@`$,`4P`V`````0`X
M0DE-!`8```````<`"``!``$!`/_A$(9H='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C`O`#P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ
M<F53>DY48WIK8SED(C\^(#QX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C`Q,B\P,B\P-BTQ-#HU-CHR-R`@("`@("`@(CX@/')D9CI21$8@
M>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S`R+S(R+7)D9BUS
M>6YT87@M;G,C(CX@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(@>&UL
M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(B!X;6QN<SID
M8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B('AM;&YS.GAM
M<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O;6TO(B!X;6QN<SIS
M=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+W-4>7!E+U)E<V]U
M<F-E179E;G0C(B!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87`O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UL;G,Z<&AO=&]S:&]P/2)H
M='1P.B\O;G,N861O8F4N8V]M+W!H;W1O<VAO<"\Q+C`O(B!X;7`Z0W)E871O
M<E1O;VP](D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I(B!X;7`Z0W)E
M871E1&%T93TB,C`Q-2TP,RTP-E0Q,SHU-CHR-BLP.#HP,"(@>&UP.DUE=&%D
M871A1&%T93TB,C`Q-2TP,RTP-E0Q,SHU-CHS.2LP.#HP,"(@>&UP.DUO9&EF
M>41A=&4](C(P,34M,#,M,#94,3,Z-38Z,SDK,#@Z,#`B(&1C.F9O<FUA=#TB
M:6UA9V4O:G!E9R(@>&UP34TZ26YS=&%N8V5)1#TB>&UP+FEI9#HT0T4S,T8T
M0T,R0S-%-#$Q.#,T.$0S.3A&,48T-3!&,B(@>&UP34TZ1&]C=6UE;G1)1#TB
M>&UP+F1I9#HT044S,T8T0T,R0S-%-#$Q.#,T.$0S.3A&,48T-3!&,B(@>&UP
M34TZ3W)I9VEN86Q$;V-U;65N=$E$/2)X;7`N9&ED.C1!13,S1C1#0S)#,T4T
M,3$X,S0X1#,Y.$8Q1C0U,$8R(B!P:&]T;W-H;W`Z0V]L;W)-;V1E/2(S(B!P
M:&]T;W-H;W`Z24-#4')O9FEL93TB<U)'0B!)14,V,3DV-BTR+C$B/B`\>&UP
M34TZ2&ES=&]R>3X@/')D9CI397$^(#QR9&8Z;&D@<W1%=G0Z86-T:6]N/2)C
M<F5A=&5D(B!S=$5V=#II;G-T86YC94E$/2)X;7`N:6ED.C1!13,S1C1#0S)#
M,T4T,3$X,S0X1#,Y.$8Q1C0U,$8R(B!S=$5V=#IW:&5N/2(R,#$U+3`S+3`V
M5#$S.C4V.C(V*S`X.C`P(B!S=$5V=#IS;V9T=V%R94%G96YT/2)!9&]B92!0
M:&]T;W-H;W`@0U,V("A7:6YD;W=S*2(O/B`\<F1F.FQI('-T179T.F%C=&EO
M;CTB<V%V960B('-T179T.FEN<W1A;F-E240](GAM<"YI:60Z-$)%,S-&-$-#
M,D,S130Q,3@S-#A$,SDX1C%&-#4P1C(B('-T179T.G=H96X](C(P,34M,#,M
M,#94,3,Z-38Z,SDK,#@Z,#`B('-T179T.G-O9G1W87)E06=E;G0](D%D;V)E
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M:2!S=$5V=#IA8W1I;VX](G-A=F5D(B!S=$5V=#II;G-T86YC94E$/2)X;7`N
M:6ED.C1#13,S1C1#0S)#,T4T,3$X,S0X1#,Y.$8Q1C0U,$8R(B!S=$5V=#IW
M:&5N/2(R,#$U+3`S+3`V5#$S.C4V.C,Y*S`X.C`P(B!S=$5V=#IS;V9T=V%R
M94%G96YT/2)!9&]B92!0:&]T;W-H;W`@0U,V("A7:6YD;W=S*2(@<W1%=G0Z
M8VAA;F=E9#TB+R(O/B`\+W)D9CI397$^(#PO>&UP34TZ2&ES=&]R>3X@/'AM
M<$U-.D1E<FEV961&<F]M('-T4F5F.FEN<W1A;F-E240](GAM<"YI:60Z-$)%
M,S-&-$-#,D,S130Q,3@S-#A$,SDX1C%&-#4P1C(B('-T4F5F.F1O8W5M96YT
M240](GAM<"YD:60Z-$%%,S-&-$-#,D,S130Q,3@S-#A$,SDX1C%&-#4P1C(B
M('-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#TB>&UP+F1I9#HT044S,T8T0T,R
M0S-%-#$Q.#,T.$0S.3A&,48T-3!&,B(O/B`\+W)D9CI$97-C<FEP=&EO;CX@
M/"]R9&8Z4D1&/B`\+W@Z>&UP;65T83X@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`\/WAP86-K970@96YD/2)W(C\^_^(,6$E#0U]04D]&24Q%``$!```,2$QI
M;F\"$```;6YT<E)'0B!865H@!\X``@`)``8`,0``86-S<$U31E0`````245#
M('-21T(```````````````$``/;6``$`````TRU(4"`@````````````````
M```````````````````````````````````````````````18W!R=````5``
M```S9&5S8P```80```!L=W1P=````?`````48FMP=````@0````4<EA96@``
M`A@````49UA96@```BP````48EA96@```D`````49&UN9````E0```!P9&UD
M9````L0```"(=G5E9````TP```"&=FEE=P```]0````D;'5M:0```_@````4
M;65A<P``!`P````D=&5C:```!#`````,<E120P``!#P```@,9U120P``!#P`
M``@,8E120P``!#P```@,=&5X=`````!#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W
M;&5T="U086-K87)D($-O;7!A;GD``&1E<V,`````````$G-21T(@245#-C$Y
M-C8M,BXQ```````````````2<U)'0B!)14,V,3DV-BTR+C$`````````````
M`````````````````````````````````````````````````````%A96B``
M``````#S40`!`````1;,6%E:(`````````````````````!865H@````````
M;Z(``#CU```#D%A96B````````!BF0``MX4``!C:6%E:(````````"2@```/
MA```ML]D97-C`````````!9)14,@:'1T<#HO+W=W=RYI96,N8V@`````````
M`````!9)14,@:'1T<#HO+W=W=RYI96,N8V@`````````````````````````
M````````````````````````````````````9&5S8P`````````N245#(#8Q
M.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="````````
M```````N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@
M+2!S4D="`````````````````````````````&1E<V,`````````+%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$`````````
M`````"Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M
M,BXQ``````````````````````````````````!V:65W```````3I/X`%%\N
M`!#/%``#[<P`!!,+``-<G@````%865H@``````!,"58`4````%<?YVUE87,`
M`````````0````````````````````````*/`````G-I9R``````0U)4(&-U
M<G8````````$``````4`"@`/`!0`&0`>`",`*``M`#(`-P`[`$``10!*`$\`
M5`!9`%X`8P!H`&T`<@!W`'P`@0"&`(L`D`"5`)H`GP"D`*D`K@"R`+<`O`#!
M`,8`RP#0`-4`VP#@`.4`ZP#P`/8`^P$!`0<!#0$3`1D!'P$E`2L!,@$X`3X!
M10%,`5(!60%@`6<!;@%U`7P!@P&+`9(!F@&A`:D!L0&Y`<$!R0'1`=D!X0'I
M`?(!^@(#`@P"%`(=`B8"+P(X`D$"2P)4`ET"9P)Q`GH"A`*.`I@"H@*L`K8"
MP0++`M4"X`+K`O4#``,+`Q8#(0,M`S@#0P-/`UH#9@-R`WX#B@.6`Z(#K@.Z
M`\<#TP/@`^P#^00&!!,$(`0M!#L$2`15!&,$<01^!(P$F@2H!+8$Q`33!.$$
M\`3^!0T%'`4K!3H%2058!6<%=P6&!98%I@6U!<4%U07E!?8&!@86!B<&-P9(
M!ED&:@9[!HP&G0:O!L`&T0;C!O4'!P<9!RL'/0=/!V$'=`>&!YD'K`>_!]('
MY0?X"`L('P@R"$8(6@AN"(((E@BJ"+X(T@CG"/L)$`DE"3H)3PED"7D)CPFD
M";H)SPGE"?L*$0HG"CT*5`IJ"H$*F`JN"L4*W`KS"PL+(@LY"U$+:0N`"Y@+
ML`O("^$+^0P2#"H,0PQ<#'4,C@RG#,`,V0SS#0T-)@U`#5H-=`V.#:D-PPW>
M#?@.$PXN#DD.9`Y_#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/LP_/#^P0"1`F$$,0
M81!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%$F02A!*C$L,2XQ,#
M$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P%1(5-!56%7@5FQ6]%>`6
M`Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8&QA`&&48BABO&-48^AD@
M&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.QMC&XH;LAO:'`(<*AQ2''L<
MHQS,'/4='AU''7`=F1W#'>P>%AY`'FH>E!Z^'ND?$Q\^'VD?E!^_'^H@%2!!
M(&P@F"#$(/`A'"%((74AH2'.(?LB)R)5(H(BKR+=(PHC."-F(Y0CPB/P)!\D
M321\)*LDVB4))3@E:"67)<<E]R8G)E<FAR:W)N@G&"=))WHGJR?<*`TH/RAQ
M**(HU"D&*3@I:RF=*=`J`BHU*F@JFRK/*P(K-BMI*YTKT2P%+#DL;BRB+-<M
M#"U!+78MJRWA+A8N3"Z"+K<N[B\D+UHOD2_'+_XP-3!L,*0PVS$2,4HQ@C&Z
M,?(R*C)C,ILRU#,-,T8S?S.X,_$T*S1E-)XTV#43-4TUAS7"-?TV-S9R-JXV
MZ3<D-V`WG#?7.!0X4#B,.,@Y!3E".7\YO#GY.C8Z=#JR.N\[+3MK.ZH[Z#PG
M/&4\I#SC/2(]83VA/>`^(#Y@/J`^X#\A/V$_HC_B0"-`9$"F0.=!*4%J0:Q!
M[D(P0G)"M4+W0SI#?4/`1`-$1T2*1,Y%$D5519I%WD8B1F=&JT;P1S5'>T?`
M2`5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FDOB3"I,<DRZ30)-2DV33=Q.
M)4YN3K=/`$])3Y-/W5`G4'%0NU$&45!1FU'F4C%2?%+'4Q-37U.J4_940E2/
M5-M5*%5U5<)6#U9<5JE6]U=$5Y)7X%@O6'U8RUD:66E9N%H'6E9:IEKU6T5;
ME5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8`5@5V"J8/QA3V&B8?5B26*<
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MEHO\C&.,RHTQC9B-_XYFCLZ/-H^>D`:0;I#6D3^1J)(1DGJ2XY--D[:4()2*
ME/257Y7)EC26GY<*EW67X)A,F+B9))F0F?R::)K5FT*;KYP<G(F<]YUDG=*>
M0)ZNGQV?BY_ZH&F@V*%'H;:B)J*6HP:C=J/FI%:DQZ4XI:FF&J:+IOVG;J?@
MJ%*HQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:ZAKQ:OB[``L'6PZK%@L=:R
M2[+"LSBSKK0EM)RU$[6*M@&V>;;PMVBWX+A9N-&Y2KG"NCNZM;LNNZ>\(;R;
MO16]C[X*OH2^_[]ZO_7`<,#LP6?!X\)?PMO#6,/4Q%'$SL5+Q<C&1L;#QT''
MO\@]R+S).LFYRCC*M\LVR[;,-<RUS37-M<XVSK;/-\^XT#G0NM$\T;[2/]+!
MTT33QM1)U,O53M71UE76V-=<U^#89-CHV6S9\=IVVOO;@-P%W(K=$-V6WAS>
MHM\IWZ_@-N"]X43AS.)3XMOC8^/KY'/D_.6$Y@WFEN<?YZGH,NB\Z4;IT.I;
MZN7K<.O[[(;M$>V<[BCNM.]`[\SP6/#E\7+Q__*,\QGSI_0T],+U4/7>]FWV
M^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?___^X`#D%D;V)E`&1`
M`````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$!`0$!`@(!`@(#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#_\``$0@`/0++`P$1``(1`0,1`?_=``0`6O_$`-D``0`"`@,!`0$`````
M```````%!@0'`0(#"`H)`0$``@,!`0$`````````````!`4"`P8!!P@0``$#
M`P`%`PL."P4##0````$``@,1!`4A$A,&!S%!46%Q@9$BDM,45!4(H;$R0D-S
MDY345=465A=28G*"(S.S-,0UAL&R)'2THE,VT>&#HT1D)95VUC=7&!$``@$#
M``0)"`8(!`4%``````$"$0,$(3$2!4%189&AT1,4!G&!L<$B,F(50G+2,U-4
MX5*R(T-5%@?QDB0U\(*B8]/#1'0E-O_:``P#`0`"$0,1`#\`_=CF,QD[?)WD
M$%Y)'%'(P,8&0D-!AC<0"Z,N-7$G24!&^?LQY?+WD'@D`\_9CR^7O(/!(!Y^
MS'E\O>0>"0#S]F/+Y>\@\$@'G[,>7R]Y!X)`//V8\OE[R#P2`>?LQY?+WD'@
MD`\_9CR^7O(/!(!Y^S'E\O>0>"0#S]F/+Y>\@\$@'G[,>7R]Y!X)`//V8\OE
M[R#P2`>?LQY?+WD'@D`\_9CR^7O(/!(#GS[F@-8WTH:-.LYD#6TZKG1!M$'!
M7@-5Y/BX<2^5M[OE#&YCY`88?$[J8:KR-416]M*ZNCGHML;-V?NVV0KV\<''
MJKN5#:XDZOF52B9#TD+N#6;C9LQDGBH:^>*PL+>O,3K6TLQ%>H%(C@W'[\TE
MSE5>\28L:JQ8G-\M(KULHN1](CB?>:S+3*VV*B.@;"QM+FX`]_N;=S0ZGXJD
M1PK,=;;94WO$.\+NBW&%M<BJ^=]1`_?;Q9^W&2^(X+Z)6WNUC\)=/60_F^\_
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MO--/O;=.-1ZBV8_TDM_X=5N5?;Y!@T&2TCM[">G.=7Q>6%Q[`6B6#!Z83:Z2
MQL^)<J-%D8\)KC58OUHO./\`2&9>!HNLQE\5(:`BZLK.>$'G_3VUN_1UVJ//
M#O1]VDER?I+:SXAW?<HKFW;ERJJYT7FPXDW^4:'8[>R"\!Y!!)CW/[,1@;(#
MV%HE;G#WH-%K9R<;(5;&1"7D:KS:R3.]V]#>7+W(Z\-H/X98$AIK6<?7#>;Y
MXN/@K/Y,AX/KAO-\\7'P5G\F0#ZX;S?/%Q\%9_)D`^N&\WSQ<?!6?R9`/KAO
M-\\7'P5G\F0#ZX;S?/%Q\%9_)D`^N&\WSQ<?!6?R9`26+WJWBGN2R;*SR,V3
MW:IBM0*@MH>YMP>=`6'S]F/+Y>\@\$@'G[,>7R]Y!X)`//V8\OE[R#P2`>?L
MQY?+WD'@D`\_9CR^7O(/!(!Y^S'E\O>0>"0#S]F/+Y>\@\$@'G[,>7R]Y!X)
M`//V8\OE[R#P2`>?LQY?+WD'@D`\_9CR^7O(/!(!Y^S'E\O>0>"0'5^\.78U
MSW7\NJT5/Z.`Z/@D!&/WPS7N5W(.J]D!/>B&GJH#&=O7O"XU\YRMZC8;4#U8
M"@.OUIWA^=9_@K3Y.@'UIWA^=9_@K3Y.@'UIWA^=9_@K3Y.@'UIWA^=9_@K3
MY.@'UIWA^=9_@K3Y.@-/<4>)6_F$N\-'B=YKVQ9<6EW).V*VQCQ*^.>)K'$S
MV$Q!:UQ&BBG8=JW<C<<X)NJ.9\0YN7B3Q%C7W!2BZT2==*XTS5HXS\4B:#?7
M)$]`L\(3VAB25,[O8_"73UE!\WWG6G?I5\D?LGM+Q#XRY>$10[Z[SV(-2+JR
MM]W;205YR^\P5Q&YHZ-5>*&+!U=N#Y'7U,]GD;[RH;,,V_#XH[$?VH-=!5KI
M_I*RR"3'>DCO#8PDU=:9'=C<V_F:/P67=ON[`RO5<TK>KV[EHGNR+?&I27K*
MNYNOQE)[5CQM>A#]6=JS)_YE;7H(:#B?QLP5W-:Y/BYO=E;VTE,4XNK/<^.U
M,C1[6&SW:BUHW`@CNP5GV.)=BI1Q81B^+:KTR(D,[?\`A79VLC?V3=O1='56
MDJ^2-M:/.2OWZ<7OMYE/B.!^B%CW3&_!73UDGY_OG^83YH?9'WY\7OMYE/B.
M!^B%[W3&_!73UCY_OG^83YH?9'WY\7OMYE/B.!^B$[IC?@KIZQ\_WS_,)\T/
MLC[\^+WV\RGQ'`_1"=TQOP5T]8^?[Y_F$^:'V1]^?%[[>93XC@?HA.Z8WX*Z
M>L?/]\_S"?-#[(^_/B]]O,I\1P/T0G=,;\%=/6/G^^?YA/FA]D??GQ>^WF4^
M(X'Z(3NF-^"NGK'S_?/\PGS0^R/OSXO?;S*?$<#]$)W3&_!73UCY_OG^83YH
M?9,>YXV<7KF(Q?>'GK:ONMG:[NQ3-ZSI<%.RGYJ+%QDZ]A%^6O687-][YN1<
M?F=V/+%03Z8/T%'R7$GTB'ZS\+Q]WGMS[6WRF[^YEU'7H-Q;[N12@=6A4B%K
M`7WF[XM<CDO64V1E^*W5X?BV_%\4[=EKG5M/H*#DN,7IDX\.=%Q0RF5C;7N\
M;8[FOD<!S^+S[MPRBO0*E2H8^Y9:\91?+M=91Y&]O[DXZ;COJ=V*_45FO,[:
M90KWTJO2EQKS'D>)V]-B\:-6[W>W5@[3G[LAI[!4F.[-US588\&N1R^T4=[Q
MMXYQWLY&^<B$OBMVE_Z1ACTN_24.D<7LX1TC$;GGUMW%E\IW=^4CSRZS5_7W
MC%ZO$%W_`"6O_&<__KKTE?\`[=SO_D^Z'_MM/E.[?RD>>76>_P!>^,OY_=_R
M6O\`QFP^'O&CTQ>)]W?6NZO%+(OCQ;;=^2OLC:;FV5E9BZ+Q;M<X[LR3322;
M-Q#6,)HTUHHN5C;FPXQ=_&57J2VFW37](OMP[X_N/XDNWK6[-]R:MTVY35F,
M8[5:?PVVW1Z$N`^G=WL9Z2QU)=\/2:SS10&2QW6W5W/J>EOG#*;NFG7;&%37
M<K=VE8^ZH^64I>A,^DX'A_QDZ2WMX[N\L;-FU^W.WZC=V'WEWRP]OL';];TY
MMY`U[K/.P-Q,2.>-MA@L?%%7G%'*NN.-QU[*$>2-?6V=EB6+N)#8>?D7GQW7
M!OFC"*18;/?K>^2Z@8_/73F.>`YI@Q]"*'0:68*TSC%1;2)UN<Y7()RT5++]
M;MY?G>?X&S^3+42S(CWUWB9027QE'/6&W8[MMAIZB`SH]]LBZ@DN[F,](9;O
M;R]2(.':*`E1O!EW`$9"4@@$'4@T@Z1[D@.?/V8\OE[R#P2`>?LQY?+WD'@D
M!8_.5_J5\:?7ZJ^/5U8OWSQC4\8_5^SU=%/8]1`?_]#]S^>_G%_[ZS]A$@(A
M`$`0!`$`0!`$`0!`$!%9?.8?`PMGR^0M[%DE=DR1VM/-3EV-NP.FD[`HLX6Y
MW'2$6R/DY>-B14\F\H)ZJZWY%K9KK(<7\';ZS<;C\ADGC0'RZEC;D]-7[29S
M?S05*A@W'[\DNDI;WB3$AHL69S?+2*Z:OH*-D.+>]-UK-L(\=B(SR.A@-W<@
M>_7)+0>LU2(X5E>\W)\Q57O$6?<T68PMQY%5\[ZBBW^<S>5<79++Y&\J2=26
MZD$(KS"&,LB`["D1MVX>[!+S%3>RLK(=;^1.7E;IS+0:MD#6R2ZH`!D?[&@!
M[H]'*LR/1<1U0!`$`0!`$`0!`$`0!`$`0`:'![26O'(]I+7BG)1[2'"G70<-
M5K++C=\]ZL3JBRSM]LVT_073Q>P$?@ZER)"!UB%JG8LSTRMJI.L;SWACT[++
MGL\3]I=-2]X_C%EHM5N5Q-C>MT!TMF]]E-U3J.VL!/8"C2P8/W)M>726UGQ+
MDQHLC'A-<:]E^M%YQW%3=6\U6W3[S%/-`?&X-I"TG_O%L9&@=4@*/+#O1U)2
M7(6MGQ!N^[17'*V_B55SHV%;W%O>0175I<0W5M,W6BN+>1LL,@Y]5[214<XY
M1SJ,TXMQDJ,NH3A=A&Y;FI6WJ:=4SV7AD$`0!`2V&_?#[R_^\Q`6I`$`0!`$
M`0!`$`0!`$`0'A<_N\OY!0%>0!`$`0!`=2]K>4@?\R`\C..8$]?0@-8[^XVR
MR=WBI;R(R^+VUTV-@D<QE'S1..N&^RTM4S&G*,9[+UM%#OG'M7YXLKL:T32Y
MT56"SM+44MK6W@ISQQ-#N_H7>JMS;EK;9`A9LV_N[45YC(7AM"&+U,T#O3_Q
M+F_\Z?V<:L\?[FWY#A]Y_P"X9?UR"6X@!`$`0!`$`0!`$`0!`=961SL,4\<4
M\1!!BGC9/&0>4&.5KV>HFIU6AB24TXSBI1XFJKI*9E.'.Y66+GSX*"UF=_VC
M&/DQ\@)]L6PNV+CUVK?#*R+>JZVN725&3N#<^55SPHQGQPK%]&CH-?9+@?:.
MUG8;/W$/+JP92V;<,'4\8MS')0=):5*AO&7\2TGY-'0461X-M.KP\Z2Y)JJY
MU1]!]%>BQN5FMTY-_&Y(6LT=V<#XM-9S;5LFQ&1$A=&]K)(B-<:"%4[ZR+=]
M8NQ5-5K7S'?_`-M-SYF[);Z61L.,G:HXNM:;5=&AK6?6Q!;H<"T]#A3UU1GU
M4X0&78_OEO[Y_85C/W6;+7WD/*6Y:":$`0%TA_51>]L_NA`>B`("V>Y_T7_%
M(#__T?W/Y[^<7_OK/V$2`B$`0!`$`0!`$`0!`=FL>_0QCGD<H:TN/J`H>I-Z
ME4ZD$&A!!'*#H(ZX0\Y.$^3.($LLN^^\6UD?)L+MMO#KN+A#!'#'J0Q`FC(V
M]`T5TJYQJ=WM:-:J?/-\-O>F8VZTE1<B26A%16\K0@'6T'I0$+=8>.5SI(7[
M)[B2YI%8R3I)`!#FU/70$5+BKV.I$0D`K^J<''EI[$T=I0&`^-\>B1CHST/!
M;Z_70'5`$`0!`$`0!`$`0!`$`0!`$`0&[.#$TVVW@M-J_P`5;!97+;?6)B9<
M/FEC?,QG(Q[V-`)'+SJOSTOW3I[6DZGPQ*6WFV]I]GLQ=."M7I-ZJO.L"`]8
MK>>8TBAEDZK6&G7UC1M$!(Q8:[?0R;.$$<A=KN'4+6:`>R@)RRL(K,$@E\KA
M1TA%-'+1K1[%M>N4!G(`@"`(`@"`(`@"`(`@"`\+G]WE_(*`KR`(`@"`QYG$
M4`-`0:]5`8Z`("D;W?KK'WB?]HQ2L?W9>5%1O3WK'G]13U(*T(`O#QZF:!WI
M_P")<W_G3^SC5GC_`'-OR'#[S_W#+^N02W$`(`@"`(`@"`(`@"`(`@"`("Z[
MF;YR[H2WI%@R_M[\0"9FV,$T;K<OU'0OU7L-1(:AP[*C9&/VZC[5&BXW1O>6
MZIW7V"G"=*JM'HXN<W!8<5=T[X".^\>Q3G4!\;M]O`T\E1/:F35ITD!0)X=^
M/NI2\GZ3K;/B?=5Y4O*=J7*JKG1*8+>W=/>=A?NYO1@,Y1SFNBQ^5M9;ECFN
M+2R2T?(RZ:\$4IJ+7<L7[.B[9G'RITY]1,P=Z[JWDJ[OWG8O_5FF_/%M-<Q;
M;-CF7MNU[7,=M.1P+3R'F("CS:V7I+2VFKL$U1U+9ST&D]`TGM#2M),,J.RN
MY::L#P#3NGC4;0\_=4*`SX\/(:&65K1SA@+CUJG5'KH">:T-:UHY&@-%>@"@
M0'*`("V>Y_T7_%(#_]+]S^>_G%_[ZS]A$@(A`$`0!`$`0$/G-XL!NQ8.RF\F
M:QN!QS7B/QS*7+;:)\I!<V&$'6DGG<UI(8QKG4TTHL[=NY=EL6H.4N)$;+S<
M/=]EY&=E6[-BM-J3HJ\2X6^1&@]X?2OX38?7CP[\]O?<MJ&C$XTV-@YPY*Y#
M*.@;J'I#"I]O=.7/W]F"Y75\R..S?[B>'<:L<9WLF:_4CLQ_S3IT(T;O!Z86
M]U[KQ[L[JX3`1&NI<9.:?.7H')4QCQ2R:ZG4>%/M[GL1^]NRD^30O6SD\W^Y
M>\KM8X&[[5F/')NY+U1])I'.<:.*V\,NTR&_6=B:':S+;%7`P]I&>;4@QS8!
MHZI*FPPL2VJ0QX^?2^DY3+\4>(<Z5;^][R7%!["7FC0G-WO2'XO;N[.-F]<N
M9MHP`VUWCM8,NW5'M1<2".\;UQ)587-WX=S2[-'\.C]!+PO&OB3"I%;Q=VVN
M"XE/I?M=)4\OZ65Q+O;G'[T[F12&6^K+=;NY`QN'Z*,%PL<B'`DTY!*I-O=*
M5FWV5[@X5ZT1LC^X,YY^3+/W:JRE5NW+D_5EUE^P7'_A5G=2,[P28&Z>!_AM
MXK*?'@.YVB\8V>S-#SZP"T3W?EPJU;VER:>C66^+XMW!E47?':F^"Y%QZ=*-
MPQ30W$4<]O+%/!-&R6&>&1LL,T4C0Z.6*5A<R2-[34$$@A0VFFTU1G11E&<5
M*$DX-536E-<C/1>'H0!`=7-:\%KVAX(H0X!PIV:H#!EQEG+[D&'IC)9R]05;
MZB`CY,&-)AN".6C9&5`Z!K-.GM("/EQ5[$*[(2@<IB<'4%.4@T<.1`8+V/C-
M'L<P]#FEI]4!`=4`0!`$`0!`$`0!`$![1V\\OZJ&1_26M-!V30(#>W!3#W;[
M[>'7V<+?$<?77=K/H;F8^Q96G;4#/7LVGP59T_AC[[-^I'TL^BH\'"W];-)(
M><-`C;_:[UE7'7$C'8VD6EEO'7I<W7/-IJ_6(.A`97-0:!T#0.UR(`@"`(`@
M"`(`@"`(`@"`(`@"`\Y6;2-[*TUFD5I6G8T("'?8W#.1HD&GV#A717VIH>9`
M8KF/8:/:YI'2"/70'5`$!C3\K>L?70'@@"`I&]WZZQ]XG_:,4K']V7E14;T]
MZQY_44];RM,>XN[2T;KW=U;VS>F>9D?::XZQ[`7J3E[J;,+EVU:5;MV,5RM(
MK-YOQN_:U$4\]_(![&SA=J5YAMIMFRAIRZ5NCCW9?1HN4K;V^L"W51F[C^%:
M.=T-/Y.]=D\C>Y%T8A-Y.Z;8AVL(P0&M;K'V1#6BIZ5/A#8A&%:T1R>3>>3D
M7K[C3;E6G$82S-`0!`$`0!`$`0!`$`0!`$`0!`<CE7AZM:/@BX8V._NIHM:&
M9MY=%LT#W03`^,2:1+$62`]E=+'W(IZJ'Q"24;UR<=$]MZ5H>M\*TGTSZ-W$
M/?R7BYPYW6N-[\]>;N97>*&SR&(O[Z2^M;BU-K=/V-;K:S1,UF`]PYO(JC>N
M)B]RR;RQXJZHU32IP\A]!\">(-^KQ)N3=TM[7Y8-R\HRA*3DFJ/1[56O,S^R
M<<,40&SC8SJM:T'KUI6NA<0?IY:CT0!`$`0!`6SW/^B_XI`?_]/]S^>_G%_[
MZS]A$@(A`$`0!`$`0'Q_Z9+6NW/W'U@'4WKR!%16A\RRZ157.Y?O<CZB])\S
M_N>D]V[HJO\`W$OV&?S]5\?'`@"`Y8UTK@R)KY7G0&1-=(XGJ-8'.*:M+U!)
MR=(IM\FGT&L,MPYWVS>\N7DLL!<QV\EY5MWD'QX^V+=FSNP9W"5S1U&%3(9>
M/;M04KGM):EI*^]N+>V7E7I6L.2A77*D5TZ>@LV-X!9"9H=G]X;*UC+>[ML5
M:R7LI!&EIGN3%"".D-*U3WC%?=6FWQMT]!8V/!EZ5'EYT8KB@MI\[HC^C6XF
MZ>)Q.YNZV/B%Q<QV6!Q]K'+<24D>R**C7/;%JL#CSTT+G+^1<G>NRT)N3/M6
MZ=U8F/NW`LI2DHVHI-OB7(6PX3&D4\7U>JV20'^\5J[6YQE@\#$:IV-/(V8$
MV[<#JFWN98CIHV1K96]L:KEDK[X8HCSW9;=7;NM/ETKK(J;`9&+2QL5R.F)X
M:ZE?P)-4U[*S5Z#UZ")/=V3"NRE)<C]3(N:">W-)X98ORV.:.W2A6Q-/4R).
MW.VZ3@T^5'B#7D7I@<H`@.CF,>*/:UXZ'`.'^U5`84F,LI*G8ZA.FL9+--.C
M2WU$!'RX/E,-QUFRMK_M-I7LH".EQ=[%[D)!2M8G!_)R]SH=5`83F/8:/8YA
M',YI:?5"`ZH`@/6.":7]7%(_JM:2.WR("0CP]X_2_9Q#\9VL>;VK*^N@,^/!
MPMIM9I)".4-I&#V>Z*`D8K&TATL@96E-9PUW=M^L@,H"@H-`Z!H"`W-P8_F&
M\?\`D+#_`%,R@Y_N6OK/T'3^&/OLWZD?2S?BK3K@@"`(`@"`(`@"`(`@"`(`
M@"`(`@"`(#@@'00".KI0&.^TMW\L8!Z6]SZVA`8S\<TU,<A!Y@X5'9(H4!%7
M=I-&YHHUPU206GJTY#0H#!V<E::CJ]8H#T%O*>8#KG_DJ4!I3B_G[S=VXP<-
MI#;327EI?2&:?:$1"*XA8`V)I`>7:U:DCD5C@V5=5S:>A-'(^)]X7<*>'"U;
MBW*,G5UT4:6HT!>;TY^]J)<C+$P\L=J&VS".@F,!Y'YRLXV+<=4:^4XN[O/.
MO>]D-+B6CT:2!>3(XOD<Z1YY7R.<]QZ[GDE;EHT+406W)UDVWRZ3A#P(`@"`
M(`@"`(`@"`(`@"`(`@"`(#D<J\/5K/@JZ_>[O_-W7[>1=+'W8^0^(S^\N_7E
MZ6;G]&S_`.>^%/\`ZK@_T=ZH&]O]NR_J^LZCP+_^Q\.__(7H9_<=<`?K5:D$
M/0@"`(`@+9[G_1?\4@/_U/W/Y[^<7_OK/V$2`B$`0!`$`0!`:*X_<+\YQ3W9
MPN/W?OL99W^#R\^4V.5?-#;WT4]B^S=#'=1,E\6F87!P+FEKN30I^[\N&)<N
M2N1;C*--'`<CXQ\/Y?B'!Q;.%=A&_9N.5)U2DG&E*JM'PZ50^$LGP$XL8FX?
M#=;IS2QLJ3?6%Y:7]AJ@T+MO;R.D`YZ%@/45Y'>&'-55Y5XGH9\EO^#?$N/-
MQGNQN/ZT9*4>=:>@QK3A3?!^KF,K#8.![JVM[>22X'XI?<"%@/YI63RH_0A7
MSBSX8O-TRLJ,.1)M]-$7"QX<[K6>JZ:VN<G(*'7OKAVH3U((-E'3MK3+)NMZ
M'3R%O8\/;MLI.<)7)_$]',J(M]K8V%@P,L[.TLV#FMX(HN3I>UH>>R2M3<I>
M\VRWM6+%A)6;,(+D213[V"YO<M>1VEO<7<AGH&V\,LQ/<M_`:X+9%J,%5I$"
MY"Y=OS5N$I.O`FR=LN'^]-]2MBRP8[W3(3,AH.G9,VLQ/4H%A+(M+Z5?(3+>
MY\^Y2MI07Q/U+2?0&)LW8[%X_'OD;*^RLX+9\C`6LD=$P-<YH=I#2>2JKY/:
ME*2X6=?8MNS8LV6ZN,4J^0D%X;0@"`$`BA`(/,0".T:A>#6J/48$V+Q\]3):
MQAQ]O%6)W;90'M+-7)K5(CW,3&N)[5I5Y-'H(F;=J$U-M=2Q\M&3-;*T='=M
MU7K8K[X8HASW7!U[.\UY=)%38'(Q5+613M'(8I`''I[B34*V*[!\+1%GN_)A
MJ2DN1^HBY89H"1-#+$1^&QS1S\Y%-%%L33U,ASA.VVIP:?*CR!!Y#7K(8G*`
M(#JYC'BCV->.AS0X=H@A`8KL?9.K6VCT\M-8=/0ZG.@.S+*TC-66\0/3JZW/
M7VQ=32AZ9(``H!0#D`T`(>'*`(`@"`W+P8_F&\?^0L/]3,H.?[EKZS]!T_AC
M[[-^I'TLWXJTZX(`@"`(`@"`(`@"`(`@"`(`@"`(`@"`(`@"`C;[V<?Y)]=`
M8*`(#6?$CAZ=^+:RGL[]ECE\6V=EJ+EKGV-W!<.8^2WG+`9()-=@+)`"!I!%
M%+Q<KN[DI1K!\6M%!OW<OS:W:G:NJ&5;K2ONM/6GPI\3/FG*\-M]\/K.N=W[
MNXA96MQC2S(PT'/_`(<NE`T<[`K:&7CSU74GRZ/2<)D[AWMBU=S"E**X8^TN
MC3T%'D#H9#%.Q\$K31T4['PR`CE!9*&NJ%(5'J=2IDG![,TU+B>A](7IX$`0
M!`$`0!`$`0!`$`0!`$!P7-'*0.N?6052X21L\3E,@1XCCKRY!Y'QP/$?7VKP
MV.G96$KEN'O32)%K%R;].QQYR\BT<^HF9-R=Z(V:YQ4CP!4MCFMY)`/R&RU)
MZRU+*L/1VA,EN;>48[7=F_(TWS5*]<6MU9R"*[M;FVD)H&3P2QN)Y*`.:*]A
M;E.,E6,DT5\[=RS)1NVY1?*FCY/W>X,<6-][NX=NSP^WFOK:2[N:7\^/?C,:
M&F>2CS?9,VEN64TU!.A7=S.P\>*5[)@G356KYE4^68/A;Q'O:Y-X&YK\X.3]
MIQV(ZW]*=$?<WH\>B)G=R-ZL3Q#XCY.QAR>`E=>;O[JX.X-[L\B^&2%E_G,J
M&LMW,M62N++:`.#GD%[Z"BY_>>^K=^S/&Q8-PEKD]&CB2Y>-GUSP3_;3+W5O
M'&WWOW(@K]EMV[-M[5)4IM7)ZM%72,>'6S[\7.'V0(`@"`(`@+9[G_1?\4@/
M_]7]S^>_G%_[ZS]A$@(A`$`0'BZXA96KP2.9O='U-"`QWWS1[!A/5<:>II/*
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M01:S-`0!`$`0!`$`0!`"`11P#ASAP#FGK@@A!KT/2B/GQ..N/UEJQKOPX:PN
M[;*`]I9*Y..J1'N8F-=KM6DF^+1Z"*FW;B.FWN9&?B2M$@[]NJY;%??#$ASW
M7!_=W6O+I(J;!9&*I9&R<#GB>-8_F/U3IZ-*V*[!ZW0BSW?DP]V*DN1]9%21
M2PNU)HI(G?@R,<T]BHH5L33U.I#E&4'LSBXOE5#HAB$`0!`$`((Y01UPA[0(
M>&Y>#'\PWC_R%A_J9E!S_<M?6?H.G\,??9OU(^EF_%6G7!`$`0!`$`0!`$`0
M!`$`0!`$`0!`$`0!`$!S(!#&Z:=S+>%HJZ:X>R")HZ3)*YC*=E%I=%I8?LQ<
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MX;.PTOK#%9J!PT.GM[:\T'G;,`96]AP6$93MOV9.+YB3=Q\;,A2]8MW8<J4N
MG7TFNLKP7W$R!>^TM+[!S.J:XR\>8`[I\4NMM$`.@44N&?DQHG)27*BCR/"N
MY[U7;MSLR^!Z.9U1KC*<`\I%K.PN>LKYNDMAR4$EE,>@&:';0$]6C0I4-Y1?
MWEIKR:2BR/!V1&KQ<R$UQ26R^=51K?+<.=^,,'ON]W+Z:!E2ZYQP9D8`![;6
MM7/>&]=H4NWE8]RE+J3XGH*/)W'O;$J[F#-P7#'VET=127G9O,4H=#*#0Q3,
M=#(".4&.0->.TI"TZM**EZ&U)4EQ/0^DY0!`$`0!`$!P2`*D@`<I.@(-6EF?
M98O)Y%P;88Z]NJ\CHK>39_".#6>JL)7+<%6<TC?9QLF_3L;$Y>1.G/J+=9<.
MMX+FCKKQ3'L-*B:;;2@<_P"B@#@#U"X*/+-LQ]VK+2UN#.G1W'"VN5U?,BV6
M?#/%14.1O[R\=_NX-2TB<><=SKS$?G*-+.N/W(I(L[/A[&C1WK\YOB7LKULO
M.+W-Q=J`<;N_#44I<30[>2M>4S7)=IYU&GD79>_=9<XVZ<>U1X^`J\;5>EEQ
MBP%X\`2R0P,YF`F2G4#&:K&TZZC[<>`M88-UI;<E%<_Z"2AW>LF4,SYISS@N
MV;#V&::=E8]I+@)$<&RO>;;YB6BL[2`-$5K;C5(+2Z)DC@1R$.E#R".D+%R;
MULDQM6HJD;<:>2OI)UN1O10.N))6MT-;,=HUHI0!H=[$#J+RAM;;I5U,IF5=
M2DD0.@:6$BO5(=5#PS&9"U?0%YC)_P!X"`.NX5:.V@,MKFOTL<UX_%<#Z@TH
M#L@"`(`@+9[G_1?\4@/_UOW/Y[^<7_OK/V$2`B$`0&#>[35;2NS]M3DUM--;
MGY.P@(U`$`0!`$`0!`$!JO>,1>>+PQ.D+S(-NV1K6M;+J,KLGM>XO81TM:05
M-M5[.-=7`4&9L]XN;#=:Z?T$(MI%"`(`@"`(`@"`(`@"`(`@,2_\4\5D\>U/
M%]4^S]EK4.KL?;;36Y*<Z]CM;7L:S7?[+LI=XIV?+ZN7R&MQR<_9Y:<U>K3E
M4TY=:M)R@"`P,@_*,A_\)M<=<W))%,G?75C;L%-#M:TQV1ED)/**,H.=91V*
M^VVER*OK1JNN^H_N(0E/XI.*Z(R-1;RGCFZ.0XIN[D45#1F[TC9[T-Z&R9N.
MVE+J?@L"FVOE]5M[=>75T%!F?U*XOL5:4?\`MZ9<\J/H->X'[_O''[`Y\#:?
MI_K`+(X_6KI_?G!NK[WS<BE7/EVRZ[.K@U]!4XO]5=I[/;:]/:4V>GU&]\-+
MQ)8V,9ZRW+N`:;1]EE,M9W(&BIV<>'O[-S@/P7`55=-8O\.5SSI=:9U&/+?"
M2[U;QFN24D_V&ND^J>#0L`,X6/NG91T5F;ICXHV6<5IM)-BVVD;-)+/*9:ZY
M>V.@I0%4^?M?N]'L:?+YSO?#*M5RJ.7>**NCV5&KI1U;;KKJER&[U7G5!`$`
M0!`$`0!`$`0!`$`0!`$`0!`$!V;J^V+@/Q6AWKN:AZJ<.HB,I+G6,(P=AAKJ
M2G<OS&7O[&,'I,=AA,B\C\X+."MU_>2DER)/TM$;(EEJ+[I9M2E\<Y17-&$O
M2:6WF'I!2%WB+L':V)UM<[F,M[_*LCH=$(S[\;<2O/4+%.M?+5[VTY?%H7_3
M4Y;/_K*3_=NS&SP]A24_-VC@V^8T7DVXMMY3B9+Q1GFUNZ=O/;W5KC*]1F.N
MKR/9U_&I13X]KLKN:L)?"ZOI2.9N+`5S_P"_GO&4Z_Q4XP_Z)2])LO=K[MO-
M<_F/S+XEM6;7Q,R[;;;,TVNC;[75Z=-%!N][VUVVUM\O$=-N_P#I[NTNX=CV
M5=.S6M>7AJ>=V-W2X^*ORC/R8H98NP)YH90$CVG#0PNK`=>R=Q>9-=+1"NU0
MXAI+FU[ESFACB.ES`YX:>R5GY2(Z5=-1PO3PX-*'6I3GKR=FNA`95AX_MAYJ
M\>V]='F_;ZW9V/<TZZ\ELT]NE.4SM=KM?Z?;VOAKZC:&'^\6C-ILS#04&:V(
M=JZ.>.MV-'442?=O/R?\4.@QOG=---GXZ?XE]LWY8@#(6V,:>=]E>W;O^KN+
M!E._4>6Q]%OSK]);VWD?QH6_^63]<?62C=:OZ(R:WXH-:<^EI)6'E)"K5;-:
ME9WD^I_B[_K=]6]EJFOGCQ+;4H:ZE?\`$ZW6TK=:[>O[C;KR5*_.^5[+^9=A
M3X]FO6?.&\@X(%[QBW9V.6I[O=QCYK,'3[&/,206Y%?P7!6EGYA]+9I\6OH.
M'S_Z3;_T[O*7_:TQYIT7,S4V1CQ+'DXB\REQ'70W*XVSLY`*\ADLLM?,<:?B
MA3H.Y_$BEY&WZ4CF[\<9/_37;DE\<8Q_9G(C6ZU.Z`!_%<7#U6M69H.R`(`@
M+3N7YM^L5IYT\6\7V<^R\<U?%_&]0>+ZVO\`H];6KJZVBJC9.WV4^SK71JXN
M$L]T=AW^SWC9V*.FUJVN#7HKQ5/HZ,5:W6<60Z*&!C)&4_%#7Q1=I4SUZ=9W
MBU:_9Y/\4B2MQA@1MW7KM/*]C&1]D0OD?3LK%[?!0DV^YU6VYORZ%T-EFL?-
M%!XEXIK?F[6O_2]W7K+7+:^E4LK7=:?N=CU].DE-.CHYNCL<RQ)#KPG"'@0!
M`9"`(`@.S-?7&SUM>HIJ5UJZ*4U=*`MC*ZC=:M=5M:\M:"M>K5`=D`0!`6SW
(/^B_XI`?_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g907623g68q31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g907623g68q31.jpg
M_]C_X``02D9)1@`!`0$!+`$L``#_X@Q824-#7U!23T9)3$4``0$```Q(3&EN
M;P(0``!M;G1R4D="(%A96B`'S@`"``D`!@`Q``!A8W-P35-&5`````!)14,@
M<U)'0@``````````````````]M8``0````#3+4A0("``````````````````
M`````````````````````````````````````````````!%C<')T```!4```
M`#-D97-C```!A````&QW='!T```!\````!1B:W!T```"!````!1R6%E:```"
M&````!1G6%E:```"+````!1B6%E:```"0````!1D;6YD```"5````'!D;61D
M```"Q````(AV=65D```#3````(9V:65W```#U````"1L=6UI```#^````!1M
M96%S```$#````"1T96-H```$,`````QR5%)#```$/```"`QG5%)#```$/```
M"`QB5%)#```$/```"`QT97AT`````$-O<'ER:6=H="`H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0``9&5S8P`````````2<U)'0B!)14,V,3DV
M-BTR+C$``````````````!)S4D="($E%0S8Q.38V+3(N,0``````````````
M````````````````````````````````````````````````````6%E:(```
M`````/-1``$````!%LQ865H@`````````````````````%A96B````````!O
MH@``./4```.06%E:(````````&*9``"WA0``&-I865H@````````)*````^$
M``"VSV1E<V,`````````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````
M````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````````````````````
M``````````````````````````````````!D97-C`````````"Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M('-21T(`````````
M`````"Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M
M('-21T(`````````````````````````````9&5S8P`````````L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0``````````
M````+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$``````````````````````````````````'9I97<``````!.D_@`47RX`
M$,\4``/MS``$$PL``UR>`````5A96B```````$P)5@!0````5Q_G;65A<P``
M```````!`````````````````````````H\````"<VEG(`````!#4E0@8W5R
M=@````````0`````!0`*``\`%``9`!X`(P`H`"T`,@`W`#L`0`!%`$H`3P!4
M`%D`7@!C`&@`;0!R`'<`?`"!`(8`BP"0`)4`F@"?`*0`J0"N`+(`MP"\`,$`
MQ@#+`-``U0#;`.``Y0#K`/``]@#[`0$!!P$-`1,!&0$?`24!*P$R`3@!/@%%
M`4P!4@%9`6`!9P%N`74!?`&#`8L!D@&:`:$!J0&Q`;D!P0')`=$!V0'A`>D!
M\@'Z`@,"#`(4`AT")@(O`C@"00)+`E0"70)G`G$">@*$`HX"F`*B`JP"M@+!
M`LL"U0+@`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#H@.N`[H#
MQP/3`^`#[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$!-,$X03P
M!/X%#04<!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&
M609J!GL&C`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E
M!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)
MN@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X`+F`NP
M"\@+X0OY#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-J0W##=X-
M^`X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)$"800Q!A
M$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3
M(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/`5$A4T%585>!6;%;T5X!8#
M%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$`891B*&*\8U1CZ&2`9
M11EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ'%(<>QRC
M',P<]1T>'4<=<!V9'<,=[!X6'D`>:AZ4'KX>Z1\3'SX?:1^4'[\?ZB`5($$@
M;""8(,0@\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_`D'R1-
M)'PDJR3:)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$H
MHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K`BLV*VDKG2O1+`4L.2QN+*(LURT,
M+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C`U,&PPI##;,1(Q2C&",;HQ
M\C(J,F,RFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I
M-R0W8#><-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\
M93RD/.,](CUA/:$]X#X@/F`^H#[@/R$_83^B/^)`(T!D0*9`YT$I06I!K$'N
M0C!"<D*U0O=#.D-]0\!$`T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(
M!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I-`DU*39--W$XE
M3FY.MT\`3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4
MVU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N5
M6^5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB
M\&-#8Y=CZV1`9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(
M:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R
M2W*F<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&
M>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>`J($*@6N!S8(P@I*"
M](-7@[J$'82`A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6
MB_R,8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4
M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY`
MGJZ?'9^+G_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H
M4JC$J3>IJ:H<JH^K`JMUJ^FL7*S0K42MN*XMKJ&O%J^+L`"P=;#JL6"QUK)+
MLL*S.+.NM"6TG+43M8JV`;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]
M%;V/O@J^A+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_
MR#W(O,DZR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'3
M1-/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N`W`7<BMT0W9;>'-ZB
MWRG?K^`VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJ
MY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[
M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____VP!#``,"`@,"`@,#
M`@,#`P,#!`<%!`0$!`D&!P4'"@D+"PH)"@H,#1$.#`P0#`H*#A0/$!$2$Q,3
M"PX4%A02%A$2$Q+_VP!#`0,#`P0$!`@%!0@2#`H,$A(2$A(2$A(2$A(2$A(2
M$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A+_P``1"`"4`LL#
M`2(``A$!`Q$!_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`
MM1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*Q
MP152T?`D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA9
M6F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*S
MM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ
M_\0`'P$``P$!`0$!`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#
M!`<%!`0``0)W``$"`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1
M"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI
M:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZ
MPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1
M`Q$`/P#]1;G4OL\S1^7NQCG=C^E1?VS_`-,1_P!]_P#UJK:G_P`?C_0?RJK0
M!I_VS_TQ'_??_P!:C^V?^F(_[[_^M6910!I_VS_TQ'_??_UJ/[9_Z8C_`+[_
M`/K5F44`:?\`;/\`TQ'_`'W_`/6H_MG_`*8C_OO_`.M6910!I_VS_P!,1_WW
M_P#6H_MG_IB/^^__`*U9E%`&G_;/_3$?]]__`%J/[9_Z8C_OO_ZU9E%`&G_;
M/_3$?]]__6H_MG_IB/\`OO\`^M6910!I_P!L_P#3$?\`??\`]:C^V?\`IB/^
M^_\`ZU9E*,9%`%AO$^&(^S=#_P`]?_K4G_"4?].P_P"_O_UJYR_OH+!6>ZD5
M,Y*@GEOH*Y;4_%$UR"ED&@C/4Y^8_P"%5&-S&K7A#=ZG>ZE\0[;3%(EMR\N,
MB-)<G\>.*RA\601D:5_Y-?\`V->>$DDDDDGKFDK3D1PSQ<V_=T/1?^%L_P#4
M*_\`)K_["C_A;/\`U"O_`":_^PKSJBCD1'UFKW_(]%_X6S_U"O\`R:_^PH_X
M6S_U"O\`R:_^PKSJBCD0?6:O?\CT7_A;/_4*_P#)K_["C_A;/_4*_P#)K_["
MO.J*.1!]9J]_R/1?^%L_]0K_`,FO_L*5/BPA=1+IC*A/)6XW$?AMKSFBCD0U
MB:O<]BM?&<-['OMH5=>^)>GZ5-_PE'_3L/\`O[_]:O';:ZFM)`]M(T;CNIZ_
M7UKI--\5(X6/40$;IYB_=/U]*B4+;'72Q49:2T9WW_"4?].P_P"_O_UJ/^$H
M_P"G8?\`?W_ZU8,;K*@>)E9&'!!SFEJ#KZ7-W_A*/^G8?]_?_K4?\)1_T[#_
M`+^__6K"HH`W?^$H_P"G8?\`?W_ZU'_"4?\`3L/^_O\`]:L*B@#=_P"$H_Z=
MA_W]_P#K4?\`"4?].P_[^_\`UJPJ*`-W_A*/^G8?]_?_`*U36_B#SRW^C[=H
M_P">F?Z5SE6]/ZR?04`;O]L_],1_WW_]:C^V?^F(_P"^_P#ZU9E%`&G_`&S_
M`-,1_P!]_P#UJ/[9_P"F(_[[_P#K5F44`:?]L_\`3$?]]_\`UJ/[9_Z8C_OO
M_P"M6910!I_VS_TQ'_??_P!:C^V?^F(_[[_^M6910!I_VS_TQ'_??_UJ/[9_
MZ8C_`+[_`/K5F44`:?\`;/\`TQ'_`'W_`/6H_MG_`*8C_OO_`.M6910!I_VS
M_P!,1_WW_P#6I#K849:(#_@?_P!:LN1_+7(&:K/(7.6H`V#XB':#/_`__K4?
M\)%_T[_^1/\`ZU8M%`&U_P`)%_T[_P#D3_ZU'_"1?].__D3_`.M6+10!M?\`
M"1?]._\`Y$_^M1_PD7_3O_Y$_P#K5BT>M`#-2^)']G7LMN=.\SR\?-]HQG(!
MZ;?>JW_"UO\`J%G_`,"O_L:Y3Q+_`,ANY_X!_P"@BLL^O:MHQ6AYE3$5%-I,
MZW5OC-=Z<IDM_#OVN(#+%-0PR_5?+_E6`/VE\D`>&R23@#^T>_\`W[J*VL);
MC!`")ZFEN/"]B-]Q#!&MV%XE"@%C5KV2T:.:I+&O6%2R]%_D=#I_QKN;N/?<
M^'OLJD94-J&6/U'EC%6_^%P_]0C_`,G/_L*\X)Z4E-TX=B%C*Z5G+\%_D>D?
M\+B_ZA/_`)-__84?\+B_ZA/_`)-__85YO11[.(_KM?\`F_(](_X7%_U"?_)O
M_P"PH_X7%_U"?_)O_P"PKS>BCV<0^NU_YOR/2/\`A<7_`%"?_)O_`.PH_P"%
MQ?\`4)_\F_\`["O-Z*/9Q#Z[7_F_(](_X7%_U"?_`";_`/L*HZC\;KJR7?!X
M<-S&!\VV_P`,/P\O^M<+2AJ:IP6Z%+%UVM)V^2_R-\?M,#OX<(_[B/\`]KH_
MX:87_H7?_*C_`/:JXS5/#]KJ8+%1%,>DBCK]1WKD=3\/76F$ET\R(?\`+1.G
MX^E;0I4I=#SJN.S"GKSW7HO\CV'_`(:87_H7?_*C_P#:J/\`AIA?^A=_\J/_
M`-JKPS'%&*OZM2['/_;&-_G_``7^1[G_`,-,+_T+O_E1_P#M5+_PTPO_`$+O
M_E1_^UUX7BN^\%_#@:M;0ZAK#LMK+\R01\,Z^I/8?3FIG1HQ5VC?#X_,:\^6
MG*[]%_D>A:3\?[W6[GR-,\*23-_$?[1PJCU)\K`%=U;^-9'A4W-@D<I'S(ES
MO`_':/Y5RUCI]MIELL&GP1P0KT5%Q^?K4]<<^1_"K'TV'A7BOWL[OT2.JB\6
M>:#_`*+C'_37_P"M4R^)03AK<J/7S,_TKF;3HWX5;K)[G4MCHAK8896($?[_
M`/\`6I?[9_Z8C_OO_P"M7.JQ1LJ<&K4-QYAVL,-_.D,V/[9_Z8C_`+[_`/K4
M?VS_`-,1_P!]_P#UJS**`-:#53/,J>5MW'&=^?Z5H5@V/_'W%_O5O4`8>I_\
M?C_0?RJK5K4_^/Q_H/Y55H`****`"BBB@`HHHH`****`"BBB@`I0,TG0<]JQ
M]3\3P6>4M?W\HZ[?NC\>]-)LF4HQ6KL:TLL<$9>9U1!U9C@5SNJ>*PKE-+&[
MG'FL/Y#_`!K"O-0N-1?==R,P!X4<*/H*@QCI6B@CSZV+E+2.B,RYN9+N9I+E
MVD<D\L<U%2GJ?K25?2QR!1110`4444`%%%%`!1110`4444`%%%%`BY8ZK<Z>
M3]GE(4]48Y!_"NIT[Q';7VU)3Y,Q_A)^4_0UQ5`XS[U+BF;TJ\H:'I=%<3IO
MB*YL"$D8SQ=-C'D#V/\`C75:?JUMJ2`V[X?',;<,*AP:/1IUX36^I<HHHJ#8
M****`"K>G]9/H*J5;T_K)]!0!:HHHH`****`"BBB@`HHHH`****`"BBB@!ES
M_JQ56K5S_JQ56@`HHHH`****`"@#)XHIK-@\4`<=K]N]QK=P(@3]S)QP/E%)
M;Z:D6#+\[>O85JZC_P`?LA/?'\A5:MNAYSI+F;`<#`IDOW&_W33Z9+]QO]TT
M%2V..-)2M25NMCQY;A1110(****`"BBB@`HHHH`*&PP(8`@]11136@&%JGA.
MWO`9+'_1YO3/R-^':N2O=.N-/EV7<;(W8GH?H:]*ID]O%=1&.XC1T/4,,U<*
MC3U.6KA(SU6C/+Z]]\%?\BII7_7LM>5ZIX-*AI-,?/<Q.?Y'_&O5O!T;1>&-
M-212K);JK`CH:6(:<4S?):,Z>(ES=OU-FBBBN0^H+5IT;\*MU4M.C?A5NLWN
M4M@J6V_UP^A_E452VW^N'T/\J0RW1110!8L?^/N+_>K>K!L?^/N+_>K>H`P]
M3_X_'^@_E56K6I_\?C_0?RJK0`4444`%%%%`!1110`4444`%+24HZT`<SXKU
M1PPL[<E1MW2D'KZ"N;"@=!6AXA_Y#MR!TPO_`*"*H5NMCQZ\W*;N%!.!D]J*
M#R#3,C(8;68'J#25<N;8G+)][J1ZU4((ZT`)1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4Z.1HI`T;%64Y!'44VC&:!IV9WFB:E_:=BLCX\Q?E?'J/\`
M]=7ZYWP;Q#=#MN7_`-FKHJPEN>Q0ES4TP_$#ZFN0OOC#X"TR\GM-1\<>#[2Z
MMI6BG@GURVC>)U.&5E+Y!!!!!Y%97[0?C^]^&/P=\3>(]%@DGO[*V5+9E7<(
M))'6-9B/1"X<_P"[VZU^2$LTD\KRW#O)+(Q9W=LLS'J2>YS7#B\7[%I)79]W
MPKP@LWHSK5:CC%.RM;5[L_:RQOK;5+*"\TV>&ZM+J-98)X)`\<J,,JRL.""#
MD$<5I6`P9"?3%?)'_!/[XBW^O_#G6/#VMB3[+X4N(_LE[*0$$4^YO)+$]596
M/LKJ.,"OK:TO;-R(K:[MYI#D[4E5B?P%=5*I[2FIVW/E\XP7]G8^IA)R5XO[
MUNOO5BW1115G`%%%%`!1110`4444`%%%%`!1110`RY_U8JK5JY_U8JK0`444
M4`%(3BE'6FMUH`0\G-!Z44'I0!AZC_Q^2?A_(56JSJ/_`!^2?A_(56K7HCB>
M["F2_<;_`'33Z9+]QO\`=--$RV..:DI6I*W6QX\MPHHHH$%%%%`!1110`444
M4`%%%%`!1110`HKOM$&_2+;=S\@K@5ZUUOA[7(#;16MPPAD0;5+'AN>*BHKH
M[L%)*;N;+*5//3L:;4LH^7Z5%61ZY:M.C?A5NJEIT;\*MUF]REL%2VW^N'T/
M\JBS5BWB((=ACT%(98HHHH`L6/\`Q]Q?[U;U8-C_`,?<7^]6]0!AZG_Q^/\`
M0?RJK5K4_P#C\?Z#^55:`"BBB@`HHHH`****`"BE^E<]XC\;Z9X=0K/+Y]UV
MMXF!;_@1Z+347+1$5*D*<>:;LCH.N,<YZ4HZUX7K_CS5M>D(:<VMMGY88&*C
M\3G)_E[5=\.?$G4='V0WV[4+4'[KM^\0?[+=_H<UM]7E8\Y9O0YK.]NYUOB+
M_D/77T7_`-!%4*9-XCL?$.J7$VFS!C\H:)OE=?E'53SCWI]5RM+4PG.,I.47
M=!1112)#&:BFMEE'0`^HJ6B@#-FMVB'(R/45#FM=ER#[U7ELU;++P>X]:`*%
M%/>)HSAQBF4`%%%%`!1110`4444`%%%%`!1110`4444`=3X-_P!3<_[R_P#L
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MX&^-`I`/3`3/S*:\^\#>,K_X?>+--U_1&VW6FS"3;T$J='C/LRD@_6NI\/Z2
M_P`0?AW<V<]S:6=UX0G22RO;Z800FVN7.^W,C?+N$N)$!_O3>E3^#OA?!'K8
MO/$&HZ!JVG:7;S7]SI^F:M%//=K!&TGE*JG.&V88CHNX]J]_#TZ.&H>QZ1T]
M3\8SG&9EG6:O,FVY5&I)]O+Y-?J??-C\5?"EWI]E=7>OZ/IK7UK%<K;7M_%#
M-&LB*ZAT9@P.&'&*Z+3=5LM9L4O=(N[6^LY03'<6TRR1O@X.&4D'!!'7M7Y3
M:_KMYXFUN]U75I/,O+^=I9F`P,D]%'8`8`'8`#M7U%^Q!\0KUGUOP;=I-/9+
M;OJ%I*!D6Q!"R*3V#%E(]P?6O+Q64>RHNI&6W3^NQ]OD?';QV/CA*M.REHI*
M^_2ZZ7_`^L](UO3O$%I]JT#4++4[7<4\^SG69-PZC<I(R/2IK/4+748'FL+F
MWN88G>-Y(9`ZJZ$AU)'&0001V((-?-/[-[?\*XT_P/G,7AWXDZ1#R>4M]9AC
MQ_P'SXAZ\O%[U/IL9U[0/#_@^ZDFBTCQ7\0M?35?)<H;BW@N+R<V[,.0KLBA
ML<E=P[UXQ^CGNNF_$;PIK.KG2M(\3:!>ZF"1]C@U*)Y21U`0-DFMFTU&TOYK
MF*RNK>XELY/*N4BE#F%\`['`/RM@@X/."#7(^,?A)X6\4^#YM&.D:=IZ0PDZ
M?<6=ND+Z?*H_=RQ,N"I4@'@C..>*\K^!_BB\7QEX;U+66;;\4_"L-Q+*W_+7
M5;!1'*P'0>9`5?C^Y0!]`OJ5G'J$5A)=6R7T\;2Q6K2J)712`6"YR5!(&1QD
M@5BR?$KPC%K(TB7Q3X=352_E_8FU.$3;LXV[-V<Y[=:\*\::M<^(?$'C7Q!I
MUS/:QWFLZ9X!TZ^@?8]K`URGV^1#V8O*8PPZ&,>E>W-\*/!A\+_\(X?#.C'1
M?*\LVAM5QC&,[OO;^^_.[/.<T`=/<3Q6D#S7<D<,,2EGDD;:J@=22>U8>C?$
M'PMXBOFLM`\2:#J5ZO6WM-1BFD]_E5B:\(\((?'NI^$O`7B^>75=$\/SZX;I
M+H9&K?V?>);6BR_WU59=Q!R&903G%>^1Z)X;T.]T^2/3]$L+T%H-/9;>**0$
MH24BX!^XK9"]@>PH`JW7Q,\'V5U+;7GBOPU#<0.8Y8I-6@5D<'!5@6X((P0:
MUQKNFMJW]E)J%BVIB'S_`+$+A?.\O^_Y>=VWWQBO$/A=XETFUM=8M+[P;KVJ
M3GQ9K"M?VWA\W,)W:A-_RUQT7.#Z8/I6?\1]&O8/BYXM\9>&(VFUWP+IFC7\
M4"#FZM&^V"[MO^!Q98?[4:4`?0-UJ-J+M;$W-O\`;6B\X6_FKYGE@XW[<YVY
M(&<8S3:\RM=7M/$'QVT74](G6YL-1\`O<VTR])(WO(RI_(BO3:`"BBB@`'6F
MM]XTX=::WWC0`E!Z44'I0!AZC_Q^2?A_(56JSJ/_`!^2?A_(56K7HCB>["F2
M_<;_`'33Z9,0L3LQP%4Y-,F6QQS4E*:2MUL>.]PHHHH$%%%%`!1110`4444`
M%%%%`!1110`9Q1DT44`2W/B^[\.67FH!<P(Z@Q2$_=)&<'M71^'?&>F^)$Q9
MRF.XQEK>7`8?3L1]*\^\6?\`($E_WT_]"%<-&[1.KQLR.IRK*<$'U%:*C&<;
MF,LRJX>KR[KL?4%F<J_L16A'`TG^R/4UP/P6UV]U^UU-=6F-Q]C,2Q,X&0&W
MYR>_0=:]*["N"<>631]/AJ\:U)5([,9'"D62!DGN:?114FX4444`6+'_`(^X
MO]ZMZL&Q_P"/N+_>K>H`P]3_`./Q_H/Y55JUJ?\`Q^/]!_*JM`!1110`4444
M`%5=5U6VT6RDN]0D\N&/J0,DGL`.YJV.M<3\7?\`D6(O^OU/_07JHJ[2,,34
M=.C*:W1R_B7XHWVIEX-'#6%L<C?NS*X^O1?P_.N(8EV+.<L3DD\DTE%=ZBH[
M'R%7$5*KO-W"BBBF8',ZG/)::L\MK(\4B$%61L$<"NK\/_$N2,+!KR-*N?\`
MCXC'('^TO?\`#\JY#6_^0E+]1_Z"*HCK6W+&4=3&%>I2DW%GT#;SI<PI+`P>
M.10R..C`C(J2LSP;;2OX:T[Y=H-NN"W&:VS8R8RNT^V:X)*SL?2TTY13MN5Z
M*4JR$B0%3GO24AO3<****`$90PP<54FLN\9'TJY10!D$%3A@0?>DK4>!9!AN
M:J2V;+DIR/2@"M12D8-)0`4444`%%%%`!113D1I&PBD_TH`;4L<#2'Y>GK5F
M"R`YD.3Z5:`P.*`.@\$6RI#=MU(9>OT-=0.U<[X-_P!3>?[Z?UKHSUK&:]X]
M;#?PD0WMI!J-I/:WL2S6US&T<T3C*R(PP5/L037Q?KW["GB<ZW>_\(SK/AY=
M),[&R%Y<3B98B<JK@1$;@"!D$YQ7VK171AL95P]^3J>;G&08'->3ZU%OEO:S
MMN?G%\9_"-_\)+/2/`]XJLP3^U+^\BSY5].^Z-=A(!*1HI49`.YY#C#"O._#
MVO7OA;7+'5M&E\J]T^9986QD9!Z$=U(R".X)%?H9^T%\"X_C7H5A#:74.FZK
MI=P7M[N2,NIC<`21L!S@X4@]BN.YKR;X??L23^'?&.EZGXLUO3=4TW3YO/DL
MXK=U,[+RBG=QMW;21W`QWKV\/F5'V%ZCUZKN?EN:\&YDLSY<+!NGIRRNO=6F
M]]=#D+[]C'Q-XFN/[8\-76A:/I>JQQWEOIVHSSK-9"1`[0.%B8?(Q9.O(4$\
MU]!?L\?`\_!KPA>6^IS6EWKFJRE[RXMLF,(N1&BEE!*@$MT!RY]J]<Z#`&`*
M2O&KX^O6AR2>A^CY;PIEN`Q'UFE%\_=O37=I=#RFQ^#-Q<?`+2_`NLW-O#K.
ME6$0M+^U9BMK?0MOAF1BH;"R`=AD;AWJEH_P6UR7X=65AK.JV&F^,--\0W6O
M6>H::'GMX;F6>63;M<(SQLLS(R\<'J<<^QT5QGTAYGJVE_$_Q7I,^BZE_P`(
MCX<AO(C!>ZMIM_<74XC(PYMX7AC5'(S@L[;<YPV!3_'/PLN9O!WA:R^&C6%A
MJ_@:[M9]#^VLRQ%(U\IX9&56;:\3,#@')`KTFB@#S'1O@G!!\$;;P+JU](+S
MR1+<:G;/N=;_`,WSS<HQ`)(G^8$X)``/>I5?XLC3_L+0>`A>*OE_VT+RY8$=
M/-^R>2/GQSL\X+N[XKTFB@#RNZ^"<VD^'_"__""ZN;7Q-X1>XEM=1U!&F34&
MN#NNDN0#G;*YWG:<JP!7CBGW'ASQYXI\4^$+WQ;8^%-/M?#.J/>S2Z?JL]P]
MPS6TT&U(WMT"C,V>7.,=Z]1HH`\M\):!X^\$VFIV%AIO@N^L[C6;^^AFFUNY
MA?9<7,DP#(+1AD!\'YCTZ]ZZC2/"MY8?$CQ/X@N'MC9ZU8:=;P(K$NKVYN-^
MX%0,?OEQ@GOP*ZJB@#Q_X:_!G5_`'Q*O]0-WIDOA*WL+BST*UC9_M-M%/<+<
M>4X*A=B/YBJ0Q.-N:];D@S_J_P`JEHH`I$%3AA@T5=*AAAA5>2W9>5Y7U-`$
M0ZTUOO&GXP:8WWC0`E!Z44'I0!AZC_Q^2?A_(56J76+B.VN9&F8*!C^0KG+W
M77ERMH#&O]]NI_PK=1;2/.J58P;N:MYJ$-DO[QLOV0=36#?ZK+>`J/W<1_A7
MO]35-B6R222>22<YIM:*"1P5,0Y:=`HHHJC!NX4444""BBB@`HHHH`****`"
MBBB@`HHHH`****`,;Q;_`,@27_?3_P!"%<*.E=UXM_Y`DO\`OI_Z$*X4=*ZJ
M7PGD8W^+\O\`,]D_9]Y@UW_>M_\`VI7K/:O)?V??]1KO^];_`/M2O6NU>=7_
M`(C/KLJ_W2'S_,****Q/1"BBB@"Q8_\`'W%_O5O5@V/_`!]Q?[U;U`&'J?\`
MQ^/]!_*JM6M3_P"/Q_H/Y55H`****`"BBB@!1UKB?B[_`,BQ%_U^I_Z"]=L.
MM<3\73_Q3,7_`%^I_P"@O5T_B1RX[_=I^AX_1117H'Q@44^*&2XD"0J78]A6
M_I_AI0`^H$,?^>:GC\:3:1M2H3J/1'G]SI-SJVJS"SC+*&`9SPJ\#J:Z32?"
M-M8;9+K_`$F=>02/E7Z"NCNXTBF98E5%'0+P!Q_]:HAT-)U&]C>GA80=WJSM
M=*&-+M<8`"<`=JM56TO_`)!=M_N59KD;N?14_@0UXDE3;(`:IRV#1_ZK#`]N
MXJ]0#BBX3IJ1DY]>"*,UI36T=P/G^5O[PJA-:O">F5]157.65)IC**0$'H:6
M@R"BBB@"*6V249.0?451E@:(\\CU`K3I"@/6@#(HJ_+9J^=GRD56-K("1M)^
M@H`AI5&XX'6IX[-V^\"H_6KD4"Q#Y<Y]:`*L5D>LGY5;2%4&$&!3Z*`"BBB@
M#IO!O^IO/]]/ZUT9ZUSG@W_57G^^G]:Z,]:RGJSU\,OW*$HI<48J#8,=?;FD
M]?;K[50U_2;77-%N['4K:*\@FC),,@R&8<KQZ@@'->=_\(?J>G_!CP]IGAVV
M_L_6Q/HD]X#$6*2I<VQN))%5U+X57+#<,A3SSP`>J`%L8YR,C%)7DVI>'_%+
M^!?BO:Z@_P!NU;5&N#ILEG`\"SYTRVC3RD,CL/WBLOWN64GC-=OX!L$TWPW#
M;QV\-LR2.76'3)-/0L3G*PNS,.W))R030!T8&3@=?2C!':N$D\*WUS\89];D
MCLO[-M=*LXX'N+1I)#+NN]_DR"0",@-'NRC9!'3BLF?3M;/B;^SDL=3VCQ?'
MJHO,?Z.UDL"Y/F9P/G!3R_O9.=NWYJ`6IZA2XYQW%</<>";1_BM::R-,B:)=
M,FDDN]O'VL2Q>6W^_LWX/ID9[5D7EIK`\1W^EQ:9J;+>^*K+48+P+_HZV4<-
MOYF9"<#YX9%\O[Q+`X(;-`'IXY&1TH"E@"O.>F*\D\0>$-=G^*T&MVUNO]EQ
M7]BLDT43?:A&(Y`Q1]^/*WF-9$*G*L2#\HK7@T2X7XR7VHWMK'):O!"MG,^E
MRRL#Y3!RMP'V1C+-E2A))Z\T6`]$`)Z4F<G`ZUS?Q%LM1U#P=?0:"+F2Y=X&
MD@M9O)FN+=9T:>*-]R[7>$2H#N'+#D=1B>`M)>UU_6Y]$TR^T7PU/96RV]E=
M*T&^[4R^=*D)YC!5HE)P-[*6`XW,`=^.1D<BBN'^"_A2]\(_#W2;77([*+4I
M+.W>Z6WM&@82^2@82YD??(&#9?(!/85W-`"444N*%J`E%%%`#3&K9XP3WJI(
MC*YSS]*NU#)]YOK0!5Z].M.$18?,.#4H4#H!3AUH`\V\8$_V_<J22%V8!/3Y
M!6+6SXP!'B&[S_L?^@+6-79'8^=Q'\67J%%%%,Q"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`QO%O\`R!)?]]/_`$(5PHZ5W7BW_D"2_P"^G_H0
MKA1TKJI?">1C?XOR_P`SV/\`9]_U&N_[UO\`^U*]:[5Y-^S^I6VUMB"%9X0#
MC@D!^/UKUGM7G5_XC/KLJ_W2'S_,****Q/1"BBB@"Q8_\?<7^]6]6#8_\?<7
M^]6]0!AZG_Q^/]!_*JM6M3_X_'^@_E56@`HHHH`****`"N:^(6AW.O\`A\PZ
M<HDGAF658^A<`$$#WYKI:1G"''4]Q33L[F=6FJD'![,^;IH)+>=H9XWCF4X:
M-E(8'TQ6MI_AV6?Y[L^2G]TCYC_A7L^J:1:ZLX>ZA1I$4A)0,,H]`:Y?4_#5
MQ8C?#F>(=UZK]1_A74JZ:MU/"EE7LGS/5&!;6<-I'LMD6,'J1U/XU/1VS2JI
M=@J`DGH!2UO=EI):(R;[FX;\*9;V\ES)Y<",[GL.WU]*WE\-22W)>_)B3@[`
M/F/^%;-O:Q6D02W144>G]30YHJ&&<G>6@EG";:SAB<@M&N&QZU+1161Z$596
M"BBB@84`X_&BB@"O+9I)EH\(W\ZIRQ/`V)!QZXXK4H8!EPP!![$9JDS&I14M
M49`8'I2U:FL!DFW/_`355_D;:X(;T(IG+*$HO4****"`HHHH&%%%%`!1110`
M4444`9^O?%C2OA=I\?\`:-MJ&I:EJ]PL&FZ9IT/FW%VXZA5XSC*_F.#72_#7
MXBR^/X-0^W^&O$'AF[TV14EAU:W\OS"P)!1OX@`.>.,CK7G?C7P1XEU37/#7
MB_X=Q6=_K'@^ZG)TV[E$2W<5Q&$<*YX5@JD<D?>SG(P?1OAWK?C776U"?X@^
M'=.\-VVZ-=/M8=1%U-C!WF5E^3&=N,$'J".`3K4A#V*DK7]=5KV,,'7Q+QKI
MU&U!/1*%XM<M[N=M'S75KKIIK<R]7^-VC:-\6=.\!SV]T]]?QJ3=KM$,$CJ[
M)$V3G<P08_WAZ&M#XN_%*R^$/A,:]JUG=7UL;N.W,=L5#98$@_,<8^6O!]>^
M!7Q'U^3Q'XRANK>QURX\10ZE8:%)%"\D@MF*VQ^T^9A=L4C_`"]#CZ5ZE^T/
MX/U[XC_#;3;/P_IHEU`ZI:W5Q:2SQCRD56W@LS;3@D#@G-5*CAU.FD].IST\
M?FD\-BG*DU)7=/W>CO96UNU;5/77;8Z/1?BWI?B+QS8>'=&AGN%U/P\NN6]^
MK+Y1A:0QA",[@V1GVJA\1?C79^!==M=`TS1-:\4^(KN`W']FZ3!YCP0Y(\R0
M_P`()'OVSC(SQ/PK^"&L_#?X[:C?6R^=X-31YH-(E,RDVJRSK-]FVYW#:YEP
M<8((.<G`T_&WA#QCX1^+LGCWX<Z3:>)8=6TM=/U'3)+Q;26,JPVR([_+MPB\
M=<YXYR!TL.JMD[JW>UWYOH7]<S26!<YP<9\]G:-VH]TOM:[/71WUL>D>#/&/
M_"8>%H]9?2-6T5B9%DL=3M_*G1D)#9&>F0<'O7$_##X]O\4]0LAIW@[Q-9:7
M>K*4U:YB4VH*9!&\'J64K]:[+P;=>)M7\*-+X]TW3]*U><R[;.RN?.6*,D[%
M9NF\`X."1D9XS@>'_LV?#+Q+\--3L(?$7@.:TN989X;W7?\`A(TE18RQD4"U
M5B,DJBY'/?N:B%.DX5&]UMK_`,'7\2Z^*QL<3A(POR23YGRZ[QM=<KY;ZZ/E
M]3T3XE?'BW^'/BR+04\-:YK]VVE_VE)_9JH_EP!W5B02#@;"2>G-=UX-\66'
MCKPOIVO:$TC6&IPB2+S``Z\D%6`)`(((/)Y'>O%OC/\`!77?B5\4C>Z;/=Z;
MIO\`PB,EG'?V]ZL.;OS9&6*1<[FC8.`P`P0>M>H?![3;_1?AKH.FZ]I$6AW^
MG6JVTUI%,LJY3C>&4D'=][KG).<]:*U.BJ,91^+J:9?B,QEF=:%>+]EKRZ66
MC75+\]^FS+?Q!\977@C1(]0T_P`/ZSXD=[@1/:Z7$'DC4JS&1A_=&T#_`(%7
M,_"7XV-\67#V/A77M+TQ[9YH=4NT4V\S)($,:L.K9+<?[)KT>[C:6TG2,?-)
M&RCG')'_`-:O/?V=O!VK>!/A!HFB>*;;['J-HUQYL/F+)LW3R.OS*2#PP/7O
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M6^IWT:BWGPRJ$5AU)R3_`,!-9?Q`_:+M/`7B_4]#?PQX@U?^Q;.*\O[JP1'2
M"!@#O8$Y`&>2<"N>_9G\!Z]\.I?L6N^")=$DGLMM]K!\1)=I<.C955MU)\O.
MYNAQQ61\8/@)XG^('Q%\9ZII;W=C;76@PIIDL-^D4=]/'LW6\J[@Q5@&`)PN
M<$GC%:JCAO;R3:Y>FOGY,X:N,SC^R:52G%NLWJN76W*W:SC'2Z2O;RNV?0^@
MZY:>)-!L=8TMRUEJ5K'<P/(NT^6ZA@2.QP:XGX1?''1?C#-K4>@VUS:G1YE7
M-PR_Z1&Q8+(F#T^1LCMWJ'6+/Q*_P%ET[P]X>&G^)'T5;"+28;B)%M&($1V/
MOV[53<ZG=G`&>>*X7X:?!CQC\*/B-X>O?MUIK^CSZ*VE:B]O:1V9L4CP\1*^
M83,2Y(W@;L9S6,:5+DFVU?6VO;_,]&KC<?'$X90IMP:7.U'K+1;ZJSU:MHM[
M'9_$KX[P?#SQ8F@1>&]>U^\.E'4Y#ID:OY<`=U8D9S@;,D^];<GQ5L;GX4GQ
M[X?L;W5M-%H;K[-"56;8I(D&"<93#9&?X3BN#^)OP6U/XB_&ZVU!KO6-)\.#
MPP;*?4-)OXX)6F\Z0F`@[CL9'Y^7!XKUSPKX3T[P;X8L=`T.'9IUA`8HD<[B
MP))8MZEB23ZDFE46'C3A;?J:8669UL57532GJHMI7OI9K2[6^][]#D?"GQNT
MKQQXML-$\*V=Y?+<Z-'JEU>J5$5BL@^6*3G/F$XX]_8UZ,>O'2O(_P!G?X93
M_#:P\5Q:CI<.FR7_`(AGDL_+E20O9*%$`RI.`,O@'D;CQS7K=8XA4U.U/8Z\
MGGBYX6-3%?&^EK6\N_GKW"H7^^WUJ:H7^^WUK$]0;2TE%`')^-="DN"+ZT4N
M47;*H&3@="*XG\#7L58>L>$[35-SQ@6UP?XX^C?45M3J=&>=B<$Y-S@><XQ1
M6EJN@WFD,?M49:/M*@RI_'M^-9P&:W33V/*E"479JPE%!&**"0HHHH`****`
M"BBB@`HHHH`****`"C&:,5>L=(GOB"B^7'_?8<'Z4-V*C!MV*./4@'ZT$8-=
MC8Z5!8K\J[Y"/F=N_P#A2W>EV]ZI$B`,>CJ,$5G[17.KZG*V^IYKXMXT67/]
M]/\`T(5Q=C87&I7<5K80R7%Q,VU(XUR6->T7'PWEUP?9KBZ%O;,RL9`F7(!Y
M`!XS[UV_ASPEI?A6W\O1[98V8?O)F^:1S[M_3I6T<1&,+'$\IJUZW-+2/];%
M7P%X7_X1+P[!:2$-<N?-N&7H7('`]@!BNAI:2N&3;=V?34Z<:<%".R"BBBD6
M%%%%`%BQ_P"/N+_>K>K!L?\`C[B_WJWJ`,/4_P#C\?Z#^55:M:G_`,?C_0?R
MJK0`444O\J`$H9@HY/X4QI>H`_&HCR<GDT`/9R3P<"F444`%'7KVHHH`R]1\
M.VNH-OP89/[R=_J*FT[1[;3`#"FZ0=9&.6/^%7J*?.TB%2@G>VI@:IQ>R@>H
M_D*J5;U7_C^E^H_D*J5HC"6X4444""BBB@`HHHH`****`"DDC25<2<^_>EHI
MW$TFK,HRV+)EHLNH[>E5\_7BM8$BHYK>.<?,"&]133.>I1[&;FBGRV[0.`W(
M/1J93.>2LPHHHH$%%%%`!11FBBP'3>#<>5>9_OI_6NCKG/!O^IO/]]/ZUT9Z
MUE4W/6PW\)!DX^M`)!X.*2BH-P[8XI<GVI**`%SD\_K1T&,"DHH`7<:"Q/4D
MTE%`!2YI**`#Z@?E2]1_/WI**`%SQU/YT9)__7244`*"1CMCICM1DXZGFDHH
M`7/K2444`+G-)12T`%5W/SM]:KZMKMEHD>Z^F4-_#$OS.WX?XUS4_B275HR\
M"F"%R1MW98@$CDU:@VKF4Z].#LWJ;E]K,%H2F?,D[A3T^M4U\3#/S0MM]G&?
MY5@YH!Q5\B.66(FWH=E::A!>)F%_F[J>"*L5PZ2-&P:,E6'0@]*V+/Q"R@+>
M@D=G7K^(J7#L;0Q">C-YXTD0I(JLK=01D&N8UCP5%-NETQA"YY\MLE3]/3^5
M=+!/'<1AH'$BGN*EJ5)Q-9TX5%JCR.]LI[";RKN-HW'KW^GK4!&*];O+&#4(
M3%=QI(A[,.GT/45QVL^"I+?=)I3&:,G_`%3??'T]:WA4ON>57P4H*\=4<K13
MI(FB<I*I1UZJPP132,&M#A:L%%%%`@HHHH`***?%$\T@2)2S-T`%#=AI7&XJ
M:ULIKQ]L"%O4]A6Q8>'#Q)?G'I&I_F:W(XTA39$JH@_A48%0YHZZ>$;^(R[#
M0(8,/<_OG[`_='X=ZUJ='$TIP@)J_!IZJ`9AN;L,\"L92OK<]&E225DBI!:O
M<'Y>%'<U?@LTA&2-S>IJP!M&!Q14.3.B,$@QZ_SJ6.X9.#\R^E144BR^D@D^
MZ1GTI:H`D=#CZ5-'<G@.,CUH`LT4`AAE2#]**`"BBB@"Q8_\?<7^]6]6#8_\
M?<7^]6]0!AZG_P`?C_0?RJK5K4_^/Q_H/Y55H`*;*2%&/XJ=3)ONK^-`$5%%
M%`!1110`4444`%%%%`&#JH(O7)_BP1^0JG70WUDMW%\IV2*/E/;\:PY[=[=L
M2*1Z'L?H:TCL<THM,BHHHIDA1110`4444`%%%%`!1110`4444`-F031,OJ.*
MREX'-;"]:QT^Z/I5(Y*\4FA:***I;F`R:9($+RL%11DL2`!7*:SXZCBW1:0J
MROT,K_='T'>H?B"[JUH@=MC%SM[9&T5QW2NFG25KGGXC$SC)QB='IOC>\MY?
M^)A_I,1.3D`,OTQ7::;K-KJL>^SD#$#YE)PR_A7E%:_A[2[BXU"UD0F&/S5_
M>=\9Z"B=-:F>'Q%1.VY[OX.B86MQ(1A9'&W\.O\`.N@-16UO':P)%`H5$&`!
M4E>?)W9]=3AR040HHHJ2PHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*4
M]*1B%&7(4`9))KD];\?VUGNBTD+<S=/,S\B_X_YYJE%O8RJUHTHWDSI[N\@L
M(&FO94AC7J6.*XC6_B!+*Q@T)"`>/.<98_1>U<KJ.I7.JW!FOI6D<]!T`]@.
M@K7\'(IFN6*C>H7:WIG.:W4%"-V>;+&3K5%"&B_$;9^&[B_D\_5WD0.<X9LN
MWU]*Z--'@%LB6X,6T8'.?SJ7-68ON`5+DV=5*A3@N]_O,.XM)+8_O%^7LPZ&
MH:Z1U#(P.""*YS&,^QH1G5I\K$H!Q113,R6WNY;5]T#E3W]#]:WK#Q!'*`EW
MB)^@/8USE`XJ7%,N%64-CNE(=05((/0@TM<?9:E-9']TP*=T8<&N@T_5X+T!
M0?+D/\#\?D>]9N+1VPK1EOH-U70K35T/VF/$F.)$&&'^-<3J_A2[TS=)&#<6
MX_C1>0/<5Z1T-)BG&;3,ZV%IU-]SQ['I2$8KT36/"-KJ6Z2#;;3DYW*ORL?<
M#^8KBM3T2ZTB0+=Q_(?NR+]TUO&I%GDUL+4IO78H44459S`.M=%X9A3R9I<#
M>6VY]L9_K7.CK78^&-,F6T)G1HED?<N\8)&!SBHJ-)'7A(-U$70"S849/H*M
MPV!)!F./]FKL5ND(&Q0#W..34E<[EV/8A3MN-1%1<*`!3J**DU"BBB@`HHHH
M`****`)K8D2X[$5:JI;_`.M'T-6Z`"BBB@"Q8_\`'W%_O5O5@V/_`!]Q?[U;
MU`%&[@C,N60$D<G)J'[/%_SS'YG_`!HHI`'V>+_GF/S/^-(;6%NL8X_VC_C1
M10`GV.#_`)YC_OH_XT?8X/\`GF/^^C_C110`?8X/^>8_[Z/^-'V.#_GF/^^C
M_C110`?8X/\`GF/^^C_C1]C@_P">8_[Z/^-%%`!]C@_YYC_OH_XT?8X/^>8_
M[Z/^-%%`!]C@_P">0_[Z/^-,DTZVE4K)"K`]BQ_QHHHNP:ON5_\`A'M._P"?
M4?\`?Q_\:/\`A'M._P"?4?\`?Q_\:**+L7*NP?\`"/:=_P`^H_[^/_C1_P`(
M]IW_`#ZC_OX_^-%%%V+E78/^$>T[_GU'_?Q_\:/^$>T[_GU'_?Q_\:**+L.5
M=@_X1[3O^?4?]_'_`,:='X=TUG`-J,'_`*:/_C11338<J[%G_A%=+_Y]?_(K
M_P"-'_"*Z7_SZ_\`D5_\:**=V'*NP?\`"*Z7_P`^O_D5_P#&C_A%=+_Y]?\`
MR*_^-%%%V'*NP?\`"*Z7_P`^O_D5_P#&H1X)T4=+/_R-)_\`%444KL3IP>Z#
M_A"M&_Y\_P#R,_\`\51_PA6C?\^?_D:3_P"*HHH4GW%[&G_*ON*.H_##PSJQ
M0ZAIOFF/.W_295QGKT8>E4_^%,>#O^@/_P"3D_\`\7115>TFMF2\-1;NX+[D
M/C^#OA")U=-'&5Z9NYB/R+U>C^'/AV)U:/3\,A!4_:)>,?\``J**/:3?4%AJ
M*V@ON1N?V=;_`///_P`>/^-']G6__//_`,>/^-%%2;!_9UO_`,\__'C_`(T?
MV=;_`///_P`>/^-%%`!_9UO_`,\__'C_`(T?V=;_`///_P`>/^-%%`!_9UO_
M`,\__'C_`(T?V=;_`///_P`>/^-%%`!_9UO_`,\__'C_`(T?V=;_`///_P`>
M/^-%%`!_9UO_`,\__'C_`(T?V=;_`///_P`>/^-%%`!_9UO_`,\__'C_`(T?
MV=;_`///_P`>/^-%%`!_9UO_`,\__'C_`(T?V=;_`///_P`>/^-%%`!_9UO_
M`,\__'C_`(T?V=;_`///_P`>/^-%%`%/4?#&G:M$([^!Y(QSL$[J#]0&&?QK
M._X5MX<_Z!W_`),R_P#Q5%%--K8SE2IRWB@_X5MX<_Z!W_DS+_\`%58L_`^B
M:>6-I9>67QN_?R'./JU%%/FEW!4::=U%?<6O^$9TW_GV_P#(K_XTJ^'-.3.V
MWQG_`*:-_C112NR^5=AW_"/Z>1_Q[_\`D1O\:K?\(;H__/H?^_TG_P`5111=
MB<4]T)_PAFC_`//H?^_S_P#Q5'_"&:/_`,^A_P"_S_\`Q5%%',^Y/)'L'_"&
M:/\`\^A_[_/_`/%4?\(9H_\`SZ'_`+_/_P#%444<S[AR1[!_PANC_P#/H?\`
MO\__`,52CP=I`.1:$$?]-Y/_`(JBBB[*4(]B['HUG$@1(CM7IF1C_,T[^RK7
M_GE_X^W^-%%(H/[*M?\`GE_X^?\`&F2Z+931LDL"NC#!!)(/ZT44`9)^'?AX
MG/\`9_Y7$O\`\51_PKKP]_T#S_X$R_\`Q5%%5S2[F7L*7\J^XEM?`>A6<PE@
ML%$B]"TKMC\V-:7]C6?_`#Q_\?;_`!HHI-M[E1IPCLK!_8UG_P`\?_'V_P`:
M/[&L_P#GC_X^W^-%%(L/[&L_^>/_`(^W^-']C6?_`#Q_\?;_`!HHH`/[&L_^
M>/\`X^W^-']C6?\`SQ_\?;_&BB@`_L:S_P">/_C[?XT?V-9_\\?_`!]O\:**
M`#^QK/\`YX_^/M_C1_8UG_SQ_P#'V_QHHH`5=)M$.5BP?]]O\:?_`&=;_P#/
M/_QX_P"-%%`!_9UO_P`\_P#QX_XT?V=;_P#//_QX_P"-%%`"QV$$3AT3##H=
(QJQ110!__]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g907623g80l95.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g907623g80l95.jpg
M_]C_X03Q17AI9@``34T`*@````@`!P$2``,````!``$```$:``4````!````
M8@$;``4````!````:@$H``,````!``(```$Q``(````>````<@$R``(````4
M````D(=I``0````!````I````-``"OR````G$``*_(```"<0061O8F4@4&AO
M=&]S:&]P($-3-B`H5VEN9&]W<RD`,C`Q-3HP,SHP-"`Q-#HQ,CHR,0```Z`!
M``,````!``$``*`"``0````!```"RZ`#``0````!````0@`````````&`0,`
M`P````$`!@```1H`!0````$```$>`1L`!0````$```$F`2@``P````$``@``
M`@$`!`````$```$N`@(`!`````$```.[`````````$@````!````2`````'_
MV/_M``Q!9&]B95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)
M#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`#P"@`P$B``(1
M`0,1`?_=``0`"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$`
M`04!`0$!`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!
M``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U
M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#
M(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F
M-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`]-L)WG7_`%A1+MH+G.AH
M$DDP``I6#WG_`%[(=H:ZI[;!^C+2'R8]I'N]R2D#^J83)_33`)D!Q;I_+`0?
MMUE]>ZJT;#^<SC_.4/LG36S%K>#HY[3^+BBU,:U@%<%GB'-(_*G:,?KZT/[J
M`FXF2]Q\]Q_O4=]G[SOO*LEK3S'WC^]1-;?$#XEO]Z5HX2A;;:W5MCA_:*-5
ME7E[6D[@2!/!U^"AL`/YOQW-_P#))4.<^YC=CF^X>YVT#0_UTD`D$;M_:_Q(
M^:))\2E!_P!82@_ZD)K,J3XE*3XE*#_J0E!_U(24PEW<E"N)-<$GD<$A%-AF
M&L<X_(#_`#G%`O.YA;;6/3)&N\#7MJB@D4U+W`$;':Z[B"?QU0][_P!]W^<?
M[T8X]#OH6[/)Y:1_G,<AOH>W\YCAXM>W^):C882);U]C`N<1!<XCP)/]Z&:6
MD@[K!!!(:]T'RC<C,J<\P2UH\2YO_DD=N+1^?:#\'-'\4;I7`9=/M9XV739>
M<:K<QX:7;"($:<.!\U=&X#4D_-4\;'PJ\HV5.#\@MB-X)#=)BL*[!_UA--=&
M6/%7JK?IV?_9_^T-'E!H;W1O<VAO<"`S+C``.$))300E```````0````````
M`````````````#A"24T$.@`````!%P```!`````!```````+<')I;G1/=71P
M=70````%`````%!S=%-B;V]L`0````!);G1E96YU;0````!);G1E`````$-L
M<FT````/<')I;G13:7AT965N0FET8F]O;``````+<')I;G1E<DYA;65415A4
M````&@!<`%P`4P!.`$<`1@!"`%4`+0!-`%<`4P`M`$8`4``Q`#``7`!B`',`
M:0!?`'``<@`S```````/<')I;G10<F]O9E-E='5P3V)J8P````P`4`!R`&\`
M;P!F`"``4P!E`'0`=0!P```````*<')O;V93971U<`````$`````0FQT;F5N
M=6T````,8G5I;'1I;E!R;V]F````"7!R;V]F0TU92P`X0DE-!#L``````BT`
M```0`````0``````$G!R:6YT3W5T<'5T3W!T:6]N<P```!<`````0W!T;F)O
M;VP``````$-L8G)B;V]L``````!29W--8F]O;```````0W)N0V)O;VP`````
M`$-N=$-B;V]L``````!,8FQS8F]O;```````3F=T=F)O;VP``````$5M;$1B
M;V]L``````!);G1R8F]O;```````0F-K9T]B:F,````!````````4D="0P``
M``,`````4F0@(&1O=6)`;^````````````!'<FX@9&]U8D!OX```````````
M`$)L("!D;W5B0&_@````````````0G)D5%5N=$8C4FQT````````````````
M0FQD(%5N=$8C4FQT````````````````4G-L=%5N=$8C4'AL0%(`````````
M```*=F5C=&]R1&%T86)O;VP!`````%!G4'-E;G5M`````%!G4',`````4&=0
M0P````!,969T56YT1B-2;'0```````````````!4;W`@56YT1B-2;'0`````
M``````````!38VP@56YT1B-0<F-`60```````````!!C<F]P5VAE;E!R:6YT
M:6YG8F]O;``````.8W)O<%)E8W1";W1T;VUL;VYG``````````QC<F]P4F5C
M=$QE9G1L;VYG``````````UC<F]P4F5C=%)I9VAT;&]N9P`````````+8W)O
M<%)E8W14;W!L;VYG```````X0DE-`^T``````!``2`````$``@!(`````0`"
M.$))300F```````.`````````````#^````X0DE-!`T```````0```!X.$))
M3009```````$````'CA"24T#\P``````"0```````````0`X0DE-)Q``````
M``H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&```````!`"]F
M9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4````!`"T````&
M```````!.$))30/X``````!P``#_____________________________`^@`
M````_____________________________P/H`````/__________________
M__________\#Z`````#_____________________________`^@``#A"24T$
M`````````@`!.$))300"```````$`````#A"24T$,````````@$!.$))300M
M```````&``$````".$))300(```````0`````0```D````)``````#A"24T$
M'@``````!``````X0DE-!!H``````TD````&``````````````!"```"RP``
M``H`50!N`'0`:0!T`&P`90!D`"T`,0````$`````````````````````````
M`0`````````````"RP```$(``````````````````````0``````````````
M```````````0`````0```````&YU;&P````"````!F)O=6YD<T]B:F,````!
M````````4F-T,0````0`````5&]P(&QO;F<``````````$QE9G1L;VYG````
M``````!"=&]M;&]N9P```$(`````4F=H=&QO;F<```++````!G-L:6-E<U9L
M3',````!3V)J8P````$```````5S;&EC90```!(````'<VQI8V5)1&QO;F<`
M````````!V=R;W5P241L;VYG``````````9O<FEG:6YE;G5M````#$53;&EC
M94]R:6=I;@````UA=71O1V5N97)A=&5D`````%1Y<&5E;G5M````"D53;&EC
M951Y<&4`````26UG(`````9B;W5N9'-/8FIC`````0```````%)C=#$````$
M`````%1O<"!L;VYG``````````!,969T;&]N9P``````````0G1O;6QO;F<`
M``!"`````%)G:'1L;VYG```"RP````-U<FQ415A4`````0```````&YU;&Q4
M15A4`````0```````$US9V5415A4`````0``````!F%L=%1A9U1%6%0````!
M```````.8V5L;%1E>'1)<TA434QB;V]L`0````AC96QL5&5X=%1%6%0````!
M```````):&]R>D%L:6=N96YU;0````]%4VQI8V5(;W)Z06QI9VX````'9&5F
M875L=`````EV97)T06QI9VYE;G5M````#T53;&EC959E<G1!;&EG;@````=D
M969A=6QT````"V)G0V]L;W)4>7!E96YU;0```!%%4VQI8V5"1T-O;&]R5'EP
M90````!.;VYE````"71O<$]U='-E=&QO;F<`````````"FQE9G1/=71S971L
M;VYG``````````QB;W1T;VU/=71S971L;VYG``````````MR:6=H=$]U='-E
M=&QO;F<``````#A"24T$*```````#`````(_\````````#A"24T$%```````
M!`````(X0DE-!`P``````]<````!````H`````\```'@```<(````[L`&``!
M_]C_[0`,061O8F5?0TT``?_N``Y!9&]B90!D@`````'_VP"$``P("`@)"`P)
M"0P1"PH+$14/#`P/%1@3$Q43$Q@1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P!#0L+#0X-$`X.$!0.#@X4%`X.#@X4$0P,#`P,$1$,#`P,
M#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(``\`H`,!(@`"
M$0$#$0'_W0`$``K_Q`$_```!!0$!`0$!`0`````````#``$"!`4&!P@)"@L!
M``$%`0$!`0$!``````````$``@,$!08'"`D*"Q```00!`P($`@4'!@@%`PPS
M`0`"$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S
M-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U
M5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1
M`R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,'
M)C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6
MIK;&UN;V)S='5V=WAY>GM\?_V@`,`P$``A$#$0`_`/3;"=YU_P!842[:"YSH
M:!)),``*5@]Y_P!>R':&NJ>VP?HRTA\F/:1[O<DI`_JF$R?TTP"9`<6Z?RP$
M'[=9?7NJM&P_G,X_SE#[)TULQ:W@Z.>T_BXHM3&M8!7!9XAS2/RIVC'Z^M#^
MZ@)N)DO<?/<?[U'?9^\[[RK):T\Q]X_O436WQ`^);_>E:.$H6VVMU;8X?VBC
M595Y>UI.X$@3P=?@H;`#^;\=S?\`R25#G/N8W8YON'N=M`T/]=)`)!&[?VO\
M2/FB2?$I0?\`6$H/^I":S*D^)2D^)2@_ZD)0?]2$E,)=W)0KB37!)Y'!(138
M9AK'./R`_P`YQ0+SN86VUCTR1KO`U[:HH)%-2]P!&QVNNX@G\=4/>_\`?=_G
M'^]&./0[Z%NSR>6D?YS'(;Z'M_.8X>+7M_B6HV&$B6]?8P+G$07.(\"3_>AF
MEI(.ZP002&O=!\HW(S*G/,$M:/$N;_Y)';BT?GV@_!S1_%&Z5P&73[6>-ETV
M7G&JW,>&EVPB!&G#@?-71N`U)/S5/&Q\*O*-E3@_(+8C>"0W28K"NP?]8337
M1ECQ5ZJWZ=G_V0`X0DE-!"$``````%4````!`0````\`00!D`&\`8@!E`"``
M4`!H`&\`=`!O`',`:`!O`'`````3`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S
M`&@`;P!P`"``0P!3`#8````!`#A"24T$!@``````!P`(``$``0$`_^$-UFAT
M='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\`/#]X<&%C:V5T(&)E9VEN/2+O
MN[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX@/'@Z>&UP;65T
M82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0
M($-O<F4@-2XS+6,P,3$@-C8N,30U-C8Q+"`R,#$R+S`R+S`V+3$T.C4V.C(W
M("`@("`@("`B/B`\<F1F.E)$1B!X;6QN<SIR9&8](FAT='`Z+R]W=W<N=S,N
M;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/B`\<F1F.D1E<V-R:7!T
M:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIX;7`](FAT='`Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"\B('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M
M+WAA<"\Q+C`O;6TO(B!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87`O,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(B!X;6QN<SID8STB:'1T
M<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B('AM;&YS.G!H;W1O<VAO
M<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]P:&]T;W-H;W`O,2XP+R(@>&UP.D-R
M96%T;W)4;V]L/2)!9&]B92!0:&]T;W-H;W`@0U,V("A7:6YD;W=S*2(@>&UP
M.D-R96%T941A=&4](C(P,34M,#,M,#14,30Z,3(Z,C$K,#@Z,#`B('AM<#I-
M971A9&%T841A=&4](C(P,34M,#,M,#14,30Z,3(Z,C$K,#@Z,#`B('AM<#I-
M;V1I9GE$871E/2(R,#$U+3`S+3`T5#$T.C$R.C(Q*S`X.C`P(B!X;7!-33I)
M;G-T86YC94E$/2)X;7`N:6ED.C,Y,D(X.#5!,S5#,D4T,3$Y,#=&0S!&044Y
M-S$P1C="(B!X;7!-33I$;V-U;65N=$E$/2)X;7`N9&ED.C,X,D(X.#5!,S5#
M,D4T,3$Y,#=&0S!&044Y-S$P1C="(B!X;7!-33I/<FEG:6YA;$1O8W5M96YT
M240](GAM<"YD:60Z,S@R0C@X-4$S-4,R130Q,3DP-T9#,$9!13DW,3!&-T(B
M(&1C.F9O<FUA=#TB:6UA9V4O:G!E9R(@<&AO=&]S:&]P.D-O;&]R36]D93TB
M,R(@<&AO=&]S:&]P.DE#0U!R;V9I;&4](G-21T(@245#-C$Y-C8M,BXQ(CX@
M/'AM<$U-.DAI<W1O<GD^(#QR9&8Z4V5Q/B`\<F1F.FQI('-T179T.F%C=&EO
M;CTB8W)E871E9"(@<W1%=G0Z:6YS=&%N8V5)1#TB>&UP+FEI9#HS.#)".#@U
M03,U0S)%-#$Q.3`W1D,P1D%%.3<Q,$8W0B(@<W1%=G0Z=VAE;CTB,C`Q-2TP
M,RTP-%0Q-#HQ,CHR,2LP.#HP,"(@<W1%=G0Z<V]F='=A<F5!9V5N=#TB061O
M8F4@4&AO=&]S:&]P($-3-B`H5VEN9&]W<RDB+SX@/')D9CIL:2!S=$5V=#IA
M8W1I;VX](G-A=F5D(B!S=$5V=#II;G-T86YC94E$/2)X;7`N:6ED.C,Y,D(X
M.#5!,S5#,D4T,3$Y,#=&0S!&044Y-S$P1C="(B!S=$5V=#IW:&5N/2(R,#$U
M+3`S+3`T5#$T.C$R.C(Q*S`X.C`P(B!S=$5V=#IS;V9T=V%R94%G96YT/2)!
M9&]B92!0:&]T;W-H;W`@0U,V("A7:6YD;W=S*2(@<W1%=G0Z8VAA;F=E9#TB
M+R(O/B`\+W)D9CI397$^(#PO>&UP34TZ2&ES=&]R>3X@/"]R9&8Z1&5S8W)I
M<'1I;VX^(#PO<F1F.E)$1CX@/"]X.GAM<&UE=&$^("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@/#]X<&%C:V5T(&5N9#TB=R(_/O_B#%A)0T-?4%)/1DE,10`!
M`0``#$A,:6YO`A```&UN=')21T(@6%E:(`?.``(`"0`&`#$``&%C<W!-4T94
M`````$E%0R!S4D="```````````````!``#VU@`!`````-,M2%`@(```````
M````````````````````````````````````````````````````````$6-P
M<G0```%0````,V1E<V,```&$````;'=T<'0```'P````%&)K<'0```($````
M%')865H```(8````%&=865H```(L````%&)865H```)`````%&1M;F0```)4
M````<&1M9&0```+$````B'9U960```-,````AG9I97<```/4````)&QU;6D`
M``/X````%&UE87,```0,````)'1E8V@```0P````#')44D,```0\```(#&=4
M4D,```0\```(#&)44D,```0\```(#'1E>'0`````0V]P>7)I9VAT("AC*2`Q
M.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY``!D97-C`````````!)S4D="
M($E%0S8Q.38V+3(N,0``````````````$G-21T(@245#-C$Y-C8M,BXQ````
M````````````````````````````````````````````````````````````
M``!865H@````````\U$``0````$6S%A96B``````````````````````6%E:
M(````````&^B```X]0```Y!865H@````````8ID``+>%```8VEA96B``````
M```DH```#X0``+;/9&5S8P`````````6245#(&AT='`Z+R]W=W<N:65C+F-H
M```````````````6245#(&AT='`Z+R]W=W<N:65C+F-H````````````````
M`````````````````````````````````````````````&1E<V,`````````
M+DE%0R`V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'
M0@``````````````+DE%0R`V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R
M('-P86-E("T@<U)'0@````````````````````````````!D97-C````````
M`"Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M```````````````L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%
M0S8Q.38V+3(N,0``````````````````````````````````=FEE=P``````
M$Z3^`!1?+@`0SQ0``^W,``03"P`#7)X````!6%E:(```````3`E6`%````!7
M'^=M96%S``````````$````````````````````````"CP````)S:6<@````
M`$-25"!C=7)V````````!``````%``H`#P`4`!D`'@`C`"@`+0`R`#<`.P!`
M`$4`2@!/`%0`60!>`&,`:`!M`'(`=P!\`($`A@"+`)``E0":`)\`I`"I`*X`
ML@"W`+P`P0#&`,L`T`#5`-L`X`#E`.L`\`#V`/L!`0$'`0T!$P$9`1\!)0$K
M`3(!.`$^`44!3`%2`5D!8`%G`6X!=0%\`8,!BP&2`9H!H0&I`;$!N0'!`<D!
MT0'9`>$!Z0'R`?H"`P(,`A0"'0(F`B\".`)!`DL"5`)=`F<"<0)Z`H0"C@*8
M`J("K`*V`L$"RP+5`N`"ZP+U`P`#"P,6`R$#+0,X`T,#3P-:`V8#<@-^`XH#
ME@.B`ZX#N@/'`],#X`/L`_D$!@03!"`$+00[!$@$501C!'$$?@2,!)H$J`2V
M!,0$TP3A!/`$_@4-!1P%*P4Z!4D%6`5G!7<%A@66!:8%M07%!=4%Y07V!@8&
M%@8G!C<&2`99!FH&>P:,!IT&KP;`!M$&XP;U!P<'&0<K!ST'3P=A!W0'A@>9
M!ZP'OP?2!^4'^`@+"!\(,@A&"%H(;@B"")8(J@B^"-((YPC["1`))0DZ"4\)
M9`EY"8\)I`FZ"<\)Y0G["A$*)PH]"E0*:@J!"I@*K@K%"MP*\PL+"R(+.0M1
M"VD+@`N8"[`+R`OA"_D,$@PJ#$,,7`QU#(X,IPS`#-D,\PT-#28-0`U:#70-
MC@VI#<,-W@WX#A,.+@Y)#F0.?PZ;#K8.T@[N#PD/)0]!#UX/>@^6#[,/SP_L
M$`D0)A!#$&$0?A";$+D0UQ#U$1,1,1%/$6T1C!&J$<D1Z!('$B8211)D$H02
MHQ+#$N,3`Q,C$T,38Q.#$Z03Q1/E%`84)Q1)%&H4BQ2M%,X4\!42%3055A5X
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M-C<V<C:N-NDW)#=@-YPWUS@4.%`XC#C(.04Y0CE_.;PY^3HV.G0ZLCKO.RT[
M:SNJ.^@\)SQE/*0\XSTB/6$]H3W@/B`^8#Z@/N`_(3]A/Z(_XD`C0&1`ID#G
M02E!:D&L0>Y",$)R0K5"]T,Z0WU#P$0#1$=$BD3.11)%546:1=Y&(D9G1JM&
M\$<U1WM'P$@%2$M(D4C721U)8TFI2?!*-TI]2L1+#$M32YI+XDPJ3'),NDT"
M34I-DTW<3B5.;DZW3P!/24^33]U0)U!Q4+M1!E%049M1YE(Q4GQ2QU,34U]3
MJE/V5$)4CU3;52A5=57"5@]67%:I5O=71%>25^!8+UA]6,M9&EEI6;A:!UI6
M6J9:]5M%6Y5;Y5PU7(9<UETG77A=R5X:7FQ>O5\/7V%?LV`%8%=@JF#\84]A
MHF'U8DEBG&+P8T-CEV/K9$!DE&3I93UEDF7G9CUFDF;H9SUGDV?I:#]HEFCL
M:4-IFFGQ:DAJGVKW:T]KIVO_;%=LKVT(;6!MN6X2;FMNQ&\>;WAOT7`K<(9P
MX'$Z<95Q\')+<J9S`7-=<[AT%'1P=,QU*'6%=>%V/G:;=OAW5G>S>!%X;GC,
M>2IYB7GG>D9ZI7L$>V-[PGPA?(%\X7U!?:%^`7YB?L)_(W^$?^6`1X"H@0J!
M:X'-@C""DH+T@U>#NH0=A("$XX5'A:N&#H9RAM>'.X>?B`2(:8C.B3.)F8G^
MBF2*RHLPBY:+_(QCC,J-,8V8C?^.9H[.CS:/GI`&D&Z0UI$_D:B2$9)ZDN.3
M39.VE""4BI3TE5^5R98TEI^7"I=UE^"83)BXF229D)G\FFB:U9M"FZ^<')R)
MG/>=9)W2GD">KI\=GXN?^J!IH-BA1Z&VHB:BEJ,&HW:CYJ16I,>E.*6IIAJF
MBZ;]IVZGX*A2J,2I-ZFIJARJCZL"JW6KZ:Q<K-"M1*VXKBVNH:\6KXNP`+!U
ML.JQ8+'6LDNRPK,XLZZT);2<M1.UBK8!MGFV\+=HM^"X6;C1N4JYPKH[NK6[
M+KNGO"&\F[T5O8^^"KZ$OO^_>K_UP'#`[,%GP>/"7\+;PUC#U,11Q,[%2\7(
MQD;&P\=!Q[_(/<B\R3K)N<HXRK?+-LNVS#7,M<TUS;7.-LZVSS?/N-`YT+K1
M/-&^TC_2P=-$T\;42=3+U4[5T=95UMC77-?@V&38Z-ELV?':=MK[VX#<!=R*
MW1#=EMX<WJ+?*=^OX#;@O>%$X<SB4^+;XV/CZ^1SY/SEA.8-YI;G'^>IZ#+H
MO.E&Z=#J6^KEZW#K^^R&[1'MG.XH[K3O0._,\%CPY?%R\?_RC/,9\Z?T-/3"
M]5#UWO9M]OOWBO@9^*CY./G'^E?ZY_MW_`?\F/TI_;K^2_[<_VW____N``Y!
M9&]B90!D0`````'_VP"$``$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$"`@("`@("`@("`@,#`P,#`P,#`P,!`0$!`0$!`0$!
M`0("`0("`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`__``!$(`$("RP,!$0`"$0$#$0'_W0`$`%K_Q`#<``$``00#
M`0$`````````````!0,$!@<!`@@*"0$!``(#`0$!``````````````0%`0(#
M!@<($``!`P("`P<)%04$"`8#```!``(#!`41!B$Q$D%189&2$P=QT2(RTQ14
M%96!H;%28H*R,U.3-'24-=46-E:6%PA"(T/457(E176BPM)C<[,D-^&#M7:&
MUE>7&!$``@$"`@4&"0@(!`8#``````$"`P01!2$Q49$206&AT3(&<8&QP4*2
M$Q05(M(S4Y,T5%7A4F)R0W,U!_#Q@A:RPB.STY2#1'3_V@`,`P$``A$#$0`_
M`/OINDLD%NK9H7F.6.FE?&\`$M<UI(<`X%I(.^$!K7Q]>/#Y>1!W)`/'UX\/
MEY$'<D`\?7CP^7D0=R0#Q]>/#Y>1!W)`/'UX\/EY$'<D`\?7CP^7D0=R0#Q]
M>/#Y>1!W)`/'UX\/EY$'<D`\?7CP^7D0=R0#Q]>/#Y>1!W)`/'UX\/EY$'<D
M`\?7CP^7D0=R0#Q]>/#Y>1!W)`/'UX\/EY$'<D`%^O)T"OE)W@R#N2`B;YFN
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MFO:2"8J^VVM[=&XUU/1T[F`^:M96E"7HX>`Z4L\S.D\?;*:V2BO-@9O;_P!2
MN8SLMN\54TZ-J>UOHG-X3WO4TN('`'*/*P?H5=_Z"UH]YD]%S:8<\'YGUF<V
M_ISI[B6M9FZ:CE=A^ZN-+3TAQ/[/..IGPGE*-*VKQTN&*YBVHYUEM;0KCA>R
M2:Z=729C!G7,-4P24M^=4QD8A]/WA.W#?QB@<%Q::T-8,LXRC47%3DI1YFGY
M"I];\SC7>*CWFD_EE@R/KAF;^L5'O5'_`"R`?7#,W]8J/>J/^60#ZX9F_K%1
M[U1_RR`?7#,W]8J/>J/^60#ZX9F_K%1[U1_RR`?7#,W]8J/>J/\`ED`^N&9O
MZQ4>]4?\L@,EMN8[Y-2,DEN4SWESP7&.G!P#R!VL(&@("^\?7CP^7D0=R0#Q
M]>/#Y>1!W)`/'UX\/EY$'<D`\?7CP^7D0=R0#Q]>/#Y>1!W)`/'UX\/EY$'<
MD`\?7CP^7D0=R0#Q]>/#Y>1!W)`/'UX\/EY$'<D`\?7CP^7D0=R0#Q]>/#Y>
M1!W)`/'UX\/EY$'<D!;SYGNM/AM5T[B['`!D`U;I)BWT!'.S??CH96N8/^%`
MX\9A&E`4/K3F'^JS^]4O\N@'UIS#_59_>J3^70#ZTYA_JL_O5)_+H!]:<P_U
M6?WJD_ET`^M.8?ZK/[U2?RZ`Y;FG,)<T&ZSX$C^%2[_Q=#*UH\L7/IBZ3X+E
M<88\YW&.&&OK8HF"CLN#(XZJ5D;`76MQ(:QH&DXJXA;T7"+]FL<%MZSY[7S;
M,HW-Q"-Y)0C-X:(ZL7S%K%TQ=*\S@V'.%VF<=R.@LS_8VDK+M[=:Z<5OZS2.
M:YK-X0O)M\T8O_E+:OS+TY7K&2DZ5,XY;D?VKX*?)\M,P_$JS+51(6C>V\5M
M!V=/1*VA-<_%Y4SA7I=XKSY5'.[JWD^5>R:]65-OI,2K+C^I:T05%QK?U&YA
MN=!3#G):>@RQDV@K&0X@%[I:C+TT;RTG3L`'=7=5,NFXQAEL8R>V4FO*5=6Q
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MI>^_ET^0V'Z(6/=+;ZE=/6/C^<_F$]T/FD/<NEWICN`)@Z5\VVF7#L74%)E-
M\0/#3U>6YP[A[);PM[6.NVA)<_%YF1;C-,[KKY&>7%*6V*I8;I4WY3`+ETE?
MJHAVGV?IZN-<T:H;C8,IT4YW@)H<N2PD]4!2H4LK?TE@EX')^<HKB\[]1Q=I
MWLE-;)4Z47O5-HP"Y]/?ZQ;3M&JZ0,T2Q-QQGH+/DZOAP&[M4^7'/`PWVA28
M6>2SU48)\[DO.4=SWA_N/:XNIF5=QVQA1DNBGCT&'O\`U<_J6B>8Y>EN_P`4
MC3@Z.6RY2B>#JP+),M-<#BI'PG+7JM([Y?.*I]_>^46XRSZLI;'"DO+3'_\`
M77ZE?_R[??(^4/\`ZVGPG+?PD=\NLQ_OWOE^?U?4I?\`C!_5W^I4`D]+M]P`
MQ/\`<^4-0_\`C:?"<M_"1WRZQ_O[OE^?U?4I?^,]%9*OGZVLXVVW7J7IF^K5
MGNE-#6T=1<Z#*M97344[0^&=MNH<LDQ\[&0YHDD:<#I`53<SR.WE.FK)SJ1>
M#P<DL5KTN1]`R>T_NCF]O;WDN\D;>TJQ4HN:I2DXO4^"-/1BM*Q9Z"R]2=+U
M#S<N:/U#=(.8YVX%]/;K-D:P6\G''9#FY8JJQ[>JX'!5=6YMI-JCEU*$>=RD
M_P#BP/>6&1YS1X99EWQO;B>R$*%*/_;E+I-KQ9YSC%&R,9CN$H8T-$D\5MDF
M?A^U*]MOC:]YW2&M'`H3C%MOA1ZB$JD(QC[63P6MX-^-X+%^(G;7G7-<T<QF
MO=3(6R-#2Z"A&`V<<!LT@W5RFDG@D2:,I2C)R>+Q)49OS,TX^-I3P.@HRWB%
M."M#L7D>=[X-$U2]W#&V!A/F&`A`25-FZXU+MAE?4-?@3LOB@U#7@YL9:<!U
M$!>^/KQX?+R(.Y(!X^O'A\O(@[D@'CZ\>'R\B#N2`__0^^6]?--Q^*3>P*`U
M$@"`(`@"`(`@"`(`@"`Y`)(`&).H(##;OG[*MEEDIZFY"IJHB1)2V^,UDC'#
M06/?&1`QX.X7KO"VK5%BH8+GT%9<YQE]K)PG7XJBY(KB_1TF`W#IE:-IMHL1
M=Z6>YU.R.`][TH)PX"]28V'Z]3<5%7O,M*M[3QR?F768+<>DC.5R#F^-&VZ)
MVCFK73QTN`WN?(?.3PXJ1&UH0U1Q?/I*JMG>9U\5[QP1?)!8=.LUOF"HJ*NE
M=)65-15R&6,F2KGDJ'%Q)TXRN=@>HI"2BL(I)<Q5SG.H^*I.4I<[;\IAZ&H0
M!`$`0!`$`0!`$`0!`$`0%:FJJJB>):*JJ:*0:0^DGEIW8\/-N:#YJPTI:))/
MPF].=2D^*E4E&7,VO(9M;NDO.-OV6NN,=RB;@.:N=/'.<-X3L$<PXRH\K2A+
MT<'S%I1SS,Z."==3CLDL>G69S;^F2%VRV[6.2,Z-J:VU#9&<)YBIV7^8'J/*
MQ?H5-Y:T>\T7@KBT:>V+\SZS/[/GG*][ECIZ2YLBJY2!'25S'4<TCC^Q&9?W
M4C\=P..*C3MZT$W*&CFTEQ;9M874HPIUTJCU*7R7XL='29<002"""-!!T$'>
M(7$L3A`$`0!`9=:?@,?]J3_F.0$D@"`(`@"`(`@"`(`@"`(")N7;Q?V7>B$!
M&H`@"`(`@*9E8-W'@&G_`,$!T$_9#9;NC7U=Y`M#Q-`SV*U,KZV=U(V:66MJ
MY7.G<Z4;3ZB1YV6'!H&)T:%9JI/ABN+1@CQT[*V5Q7DZ6,N-O3IUMEXQC(QL
MQ,9$WTL;&L;Q-`"U\)WC&,%A"*2YM!V63)!YF^SE[^(2>S8MZ7TM+PD+,ON-
MW_+?E1Y_&H=0>@K4\(<H`@"`(`@"`(`@"`(`"0<02#OC0>-#/@+&NM5JNC#'
M<[9;[@T@C_JZ2&9VG>E+>='F.68RG#3";3YF<*]M;7*X;FVIU%^U%/IUFOKE
MT0Y,KMIU+!76:5VD.M]4Y\`=O][57.LV>`$*5"^N(ZY*2YUU%'<=U<HKXNG"
M=&7[+T;I8FOKKT(W2)DKK1>J.N;LNV(:Z&2BF.@X#G8^>@Q\P*5#,8-KVE-K
MP:2AN>YUS%2=I>0FL-4EPO>L5Y#]+\@T%5;\AY,HJF+9J*3*]DIYPPB1@EBH
M(6/#7MQ#FAPT'=7D+J:G=7,HZG-^4_1>14*MODN4TJJ^7&VIIX:=*BDS*EP+
M4(#(+-[5/_Q&^P7&IVB5;]F7A\Q,K0[A`2-K^%M_L/\`00&3H`@"`__1^^6]
M?--Q^*3>P*`U$@"`(`@"`(`@"`(`@._-O#=LL?L>FV7;/*PP0S@\,<'@8QG&
M:6#*68YH)'PS1VF<QRQ.+)(RYT<;BQ[<"UQ8\C$;ZZT$G7I)K1Q$#,Y2CEU[
M*,L)*F]*\1X_C`#&@:!L@^:1B2=\DJ[/G"6"P6H[H`@*,\+*B,Q2C%CM8W01
MI:X'<+2@(&:R2@DP2M>-QLG8NY0Q:?.0$=+0UD/;P/PT]DP;;<!CNMQWD!:'
M02#H(UC=0!`$`0!`$`0!`$`0!`$`0!`$!P0",#P'>((U$$:0X'41I"!I/6>P
M\J3SU65\OU%3*^>>:U4KI9I';4DC@TMVGN.ESMEHTZRJ.JDJM1)8+B9])RZ<
MJF7V4YR;FZ:Q;ULGUS)@UZ`"3O`$GB&E`7<5!638%E.\-)'9R?NVX;^+\#AY
MB`DH;)(2#/*UH_:9'V3NIMG!HQZA0$_%$R&-L48V6,&`'HDG=)*`J(`@"`(`
M@"`(`@"`(`@"`B;EV\7]EWHA`1J`(`@"`L7N+B<3C@3AP:=Q`=4!R-8ZH]%`
M:?J_A53\9J/^<]6"U+P+R'F*GT]?]Y^4MUL:A`0>9OLY>_B$GLV+>E]+2\)"
MS+[C=_RWY4>?QJ'4'H*U/"'*`(`@"`(`@"`(`@"`(`@"`X(Q!&_H0&Z,O=+$
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M#`+0[E[%;*N328Q$-&F1V!P(.G9&T4!+4=N[VDYUTFV\`@!HP:,>$DD^<@)-
M`$`0'__2^^6]?--Q^*3>P*`U$@"`(`@"`(`@->YLZ6>C;(TTE+FC-]LM]QC:
MUS[1`)KC=V[;0Y@DH:*.5\+I&G$"0M.'`I%*TN:ZXJ5%N.W4M[*7,>\>193*
M5/,,SIPK+7!8RGZL<</'@:"S#^L7*-+MQ94RE?KZ\8AE9=YH+%1$[CA`.^ZY
M[-WM6E6%/)JKP=6M&/,M+\R/'WG]S<MIMQR_+:U9_K3:IQW:9=!H[,'ZJNE2
M\<XRUR67*L#\0UMJH!5U;`<1HK[D9W;7"UC5.IY59P[2E-\[T;D>3O?[A=X;
MGB5O*E;P_8CC+UI8Z?$C5C>E?I097>,F](.;>_=K;YTW>H<S'>-,3WJ6>IV,
M%*]TM>'A]WAP^`\\N\.?JM[?XS<^UV\;PW:O%@9K6_JGZ4;=E:^4MW=9,T4[
M[9)&\W*@%%6D<Y%B[OVVNAVGZ-;HW+E#*K25:FX*4)8\CQ6YEQ+^X&?T[*YI
M73I7%-PP^5'AER>E'#I1A%A_53E6I$<>9,M7NR/(#75-MD@O-&-`[(QCO:L:
MWUI4JIE558^SJQEX=!7VO?RPJ8*]LJM)[8X37F9NS+/25D/.4C8,MYGM]?6/
M8YXMLG.T5SV8QC(10U<<4K^;&EVQM8#3J4*K:W%'34I-+;K6\]/99WE.8M1L
M[Z$ZGZNJ7JLSA1RS"`(!CAJ0%&6"";VV*-^YBYHQX\,4!'RV>EDQV-N$G=8=
MH#UKL?10%A+9)Q[3+'(-.AX,;MW#3V3<4!'2T-7#CMP28>F:-II&_BW'1U4!
M:ZC@=!WMU`$`0!`$`0!`$`0!``"3@`2=X:3Q!`7<=!62]K3O`(Q#GX,;AACC
MBXC`(#V9D>R3.RCEHS31Q_W32Z(P9#AV6C$[+525UA6JIZ^(^CY7_3;'^6C-
M8K/21]N'S'##LW8#DLV5R)Q(1P0Q#".*-G"UC0>/#$H"J@"`(`@"`(`@"`(`
M@"`(`@"`("RJZ9TY:6.:"T$8.T`XG?W$!&/I:AG;1.(&ZW!XT88]KB=U`6Y!
M&L$=5`$`0%@=9ZI]%`<(#D:QU1Z*`T_5_"JGXS4?\YZL%J7@7D/,5/IZ_P"\
M_*6^YCN#6=P=4K)KS\A%U=\LU!B*NYTD3AKC;()I?,CAYQV*WC3G+LP9&JWM
MG0Q]K<P3V8XO<L3!<PYUMU;;JRVVZ"IG-9%S#ZF=G,0QQES7.>QA)DD>0W`:
M`%)I6\E.,YO!+24E_G%O6H5:%O"4G)88O0EX.5ZC60T:%-/-A`$`0!`$`0!`
M$`0!`$`0!`$`0&I^F9K79.8UP#FF\T&(<`0>PJ=8.@J98?>/]+/,=[M.413U
M>VCY&>:;7<[K8IVU-CNMSLU0UP<V6UU]50N!!QU4\K&'S0K><(55PU(1DN=)
MGSRVN;FRFJEE<U*,URPDX^1H_53]%F:LR9VR?G:JS?>:S,53:<S6NAMU1<S'
M--34<UH?/)!MMC890^8;1+]IV.ZO'9[0HV]Q15"FHIP;>&W$_17]K,WS/-\L
MS2>9WLZ\Z=>,8N6EI.&.&/+IVGM-H#1@T!HWF@`>=@J,^HG*`(`@"`(#_]/[
MY;U\TW'XI-[`H#42`(`@"`(`@`0+6C\ENGAK1TR](Q#0"[,&D@#$_P!W4&LZ
MRO76/W*V_=\Y^<>]J7^Y\[?+[;_EB:F4D\\$!P2!K('5T(8QPUEA>K;<;E8;
MQ#;J"LKII*&1K(Z6GDF+G%\>#06MV03PD+>G.$*M-SDDL3%2A7N+>O&A0G.7
M#R)LUY:NAS/=Q#'3T=%983A^\NM6WG<,,3_TM+S\F(X2%*G?V\<<&Y/F7G9!
MM^ZV;U\'.G"E';-Z=RQ9Z"Z'>A6CL>?<M7>XWZ:X5M'45+XZ>BHV4M("^AJ8
MW-=-,Z2H>W!QU`:577N82G0JPA3PBURO%Z]Q[+NUW3I6N;65Q7O93J1D\%%)
M+3%K6\6>[FV2V-`;WN78;KY)"3U3M!47M:GZQ]95A:+^%CX6SI)8;<\=BR2(
M[\<KO0?M`HJTUK>)K++[66J+B^9]9&39:D&)IJMKAN,GC+3RV$CSENJZY8D6
M>5R_A5D_#UHBIK1<8,2ZE<]HT[<)$K<.$-[(<2Z*I!^EI(D[.YIZZ3:YM)'.
M!8[9>',=Z5S2T\1`6^O417HUZ`@"`X0%&2F@E!$D,;\=]HQY6L("PEL]))CL
M<Y"[<V7;31ZUV/HH"/ELE0T_NI8I1O.QC=P:3B,4!'R457%I?!(`-;FC;:,/
M5-Q"`M<,-!T%`$`UG`:3O;J`NXZ"KE[2!^&^\!C>#2XC%`2$=CF)!EFCC&\P
M%[CIU8G9`0$A%9Z2/`O#YCZMQ:WDLP]%`7\<$,0`CBC8!JV6@'CPQ*`JNU'J
M'T$!Z\R7]D,M?Y13?ZRI;G[Q6_>/H^5_TRQ_EHR9<2<$`0!`$`0!`$`0!`$`
M0!`$`0!`$`0!`='1L>,'L:[J@%`6SZ&!VH%A]2='$<0@+5]N</:Y`X:=#@6G
M@U8C!`0CX)6N(+"=)U$'=.\@.C8I':F.ZI&`XS@@*\=*]SFAQ#<7`;YUC>T(
M96EI'CG,&>;RVZW2EI(Z2DCI[C7P-D$;IYGB*KEC#RZ4[#2[9QPP."OJ5M!P
MA*3;;2\A\MO<ZNU<W,*4802J26UZ&URF$5=WNE>3WY<*N<']ATSFQC@$4>PP
M#S%)C3A'5%%/5NKFM]+7D_'HW+01P`&H#BT\:W(YR@"`(`@"`(`@"`(`@"`(
M`@"`(`@"`U1TR?8]G^<T'L*E3+#[Q_I9YGO=_28_SH>1GEM71\U/U"_0)]B.
MD?\`]X6?_P!"D7D>\?WFW_<?E/O_`/9O^E9W_P#JA_VV>\UYT^Q!`$`0!`$!
M_]3[Y;U\TW'XI-[`H#42`(`@"`(`@"`\'=,WZ=ND"_9VS-G++C[+>:"_5HN+
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MS<-LK&1B.)HIW!K(VMC;K;@`Q@:/.7-:9)\Y,J\,*$XQ22PU+08I0V.\W/#O
M"UUU2T_Q&0/;%YLL@9&!YJ[2J0AVI(@TK2ZK_0V\Y>+1O>@V7E#(M\MUXH;O
M<>]*6&D,C^]A-S]5(Y\+X@TB(&*,`OQ)+CJ46M7IS@X1Q;9>9;E5U0N:=Q6X
M8QCCHQQ;T8<F@W(HAZ0(`@"P"G)%%,-F6*.0;TC&N]$$K*;6IF)0A-83@FN=
M$7-8K;-CLQ/IW''LH)"T`G=V';35T56:>EXD2IE]K/2HN+YGYB*FRU*,33U3
M'C3@V=A8X[PVF;3?.6ZKKTH[B)/*Y+Z.LGX5ATD5-:;C!I?3.>-UT)$K?]`E
MWG+HJD'JD0YV=S33;I-KFTD>[%IP>"P[SP6GB=@MR,]#P:P80!`$!1DIX)?;
M(8W\+FC'C&!0%#Q=0X@][1Z-0[/#<]5P("O'!#%[7%&S#5LM`/'K0R5D,!`$
M`0'!U'J'T$!Z\R7]D,M?Y13?ZRI;G[Q6_>/H^5_TRQ_EHR9<2<$`0!`$`0!`
M$`0!`$`0!`$`0!`$`0!`$`0!`0+^W=_:=Z)0'5`<@D$$:P01U1I0:CS+G3H7
MO+[G6W7+$\%QI:^HFK)+=5S-I:ZDFJ)'2S1PS/P@JX#(XEF):]H.!Q5M;W]-
M0C"LFFEACK3ZCP6:]U;IUZMQE\E.G-N7"WA)-Z7@]36.K4T::NN6,R60D7:Q
M72B:-<LE)(^#JBHA$L)'KE/A6I5.Q4BWX3R]QE]_:-JYLZD%MP>&]8H@6O8[
MM7-)W@1B.J-8*ZD--/4SL@"`(`@"`(`@"`(`@"`(`@"`-[-P8P&1Y.`9&"]Y
M.\&L!.*>%A?*>$=+YC(*/*N8JX;4%IJ@PZ0^<-IFGJ<^YCCQ+C*XHPT.HL2?
M1RR_KZ86LL-KT>7`XK,JYBH6[=1::HLW7P-;4M'5YASRWS0L1N*,W@JBQ%;+
M+^@FYVLL-JT^3$TITL6^XW++,5#;;;<;E7/O=O:RBH*&JK*MQV:D8"GIXI)?
M.5C93A&LY2FE'A>EM(\=WIHUZ^6PHT*$YUO;Q^3&+E+4^1)LQ;*?Z5NG3-IA
M?%DN7+M%-LGQCFZJALD,<;L/WII'F6YR-:#CLMAQ*D5LXR^CBG7XI;(K'IU%
M/EW]O.]V9<#CE;H4GZ5:2II<^&F3]4_4+H&Z%J#H0R?46"*[R7Z]7JO9=\QW
M81.I:*6OCIA2P4MKHW%TD%!108M:YY,DKB7.PT`>2S&_EF%=5'#AIQ6$5RX;
M6]K/T!W/[JT>Z>63LXW+K7=6?'5GAA%RPP2A'DC%:%CI>MF[5`/5A`$`0!`$
M!__5^^6]?--Q^*3>P*`U$@"`(#ASFM&+G!HX2`@+=U7"W42X^I!XL3@$!;NK
MG?LQ@;VT2?.&"`MW5$SM;R.!O8^AI0%$DG222=\DD\9TH!B0",=!UM.EIX"T
MX@A!S<ACURRGEB[XFX6*WRO=KFBA%+4=42TW-.QZN*ZPK58=FH_*0J^76%SC
M[:T@WM2X7O6!B@Z)LH<_SI%V,6./>IKSS7]GG.;YXM]<NOOE?##1CX"O_P!N
M9;Q8XU>'9Q>?#$FJC*F6;1:+B;=8[?!(VD?A.^$5-1B"S3SU3SKL=&Y@M(UJ
MTZD>.JVL25/+[&VMJOL+2">&O#%[WB8%B2`"=`U#4!U`-`4LJ<7@CA`$`0!`
M$`0!`$`6`4Y(H9ALS112C>D8U_GD8K*;6ILQ*,)IJ<%)<Z(J:PVV4DMC?3N.
M[#(0T?\`EOVFKHJLURXD.>7VT]*BXOF?F(N;+<HQ-/4LDWFS,,9/!M,VF^<M
MU77I1(D\KDL73JIK8T14UJN$&)?3/<T:WPX2M\W9[(>:%T52#]+21*EI<T\6
MZ3:YM/D(_?!Q!&@@@@@[Q!T@K<C;5RA`$`0!``"=0)ZB&0A@X.H]0^@@/7F2
M_LAEK_**;_65+<_>*W[Q]'RO^F6/\M&3+B3@@"`(`@"`(`@"`(`@"`(`@"`(
M`@"`(`@.0USC@T%QWF@D\0TH->HL+G=;39873WFZVVTPM:7%]QK:>DT`8D[$
MLC9#HX%M"$ZCPIP<GS(XU[BVM8N=U<4Z</VI)?I->5F?<MPXOIZJ2X;?9QFB
MA<^*1KQM,<V>3FX]ES3B"NBMZKUK#PD*IF]C%)PJ.>*T<*T;V8Q4])4Y)%%:
M86MW'U=0][B.%D(8T<9756J]*;($\]G_``K9)<[Q\A;,Z2;H'`R6RWO;NACZ
MF-WF$O<%M[M#]9G..>7"[5"#7C)ZCZ1K7+@*ZDJZ)QUOC#:J('UA9*!ZTKG*
MVFNS),FTL[MY?2TY0>]=9EU#F&RW`;%'=:20O`Q@DE$+R2.U=!.&$G@P*XRI
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MF\+JSJ0YW%X;UBB$:]C^U<UV_@0<.KAJ70BIIZF=D`0!`$`0!`-;@T!SGN[5
MC&N>\]1K07%8&MI+2R?H<K9BN(:ZFM-4V-W\6I`I(AP[4Y82#P!<I7%&#PE4
M6.\GT<LO[CZ.VDH[7\E=)EU%T8W"3`W"XTU*-&,=,Q]3)PC;=S<0/*"C2OH+
ML0;99T>[M9X.O<1BMD5B]^A&6T'1WER`MYZ&LNDHPQ;/,[F]K_@4P8T@'<*C
MSO*\M":CX"THY#80PXH3JRYWHW(S^W99-,UK:"T4UO81H<(8J<X<+R#*3BHL
MZKEIG-MEW0RYTTE0M8PCX$OTF019=D=IJ*H#'6(FESNIMOP'G+DYKD1.C8-_
M25=WZ24ALENA()B=,\:G3/<[_1:6M6..6G22(6="&GA;?.3-(XTCR^D#:1Y;
M@9*9C(9"-&@R1M:]PZI*TUZV2HI0>,(I/F23WZR49<ZH'LW-ETXDR#LCHW7`
M@E`7D=TC.`DC<WA:0X8]30<$!>1U=-)VLS`?2N.P[S`[#%`7'"-(WP<1QC0@
M"`(`@"`__];[Y;U\TW'XI-[`H#4.(WQQA`,1OCC"`8C?'&$!!2R[;W%T@)Q(
M&+AH`T`#<&A`4]MGIF\H==`-MGIF\H==`-MGIF\H==`-MGIF\H==`-MGIF\H
M==`-MGIF\H==`-MGIF\H==`6]7%'5TM12ND#&U$+XBYI:2W:U.`)P.!`68OA
MDI+D-*D%4A*FW@FC6E7E^YTA=LPBKB&.$M*X/Q&YM1DB1APW,"ID:L)<N#*.
MI97%/'"'%':NHA7_`+H[,H,3AK;*#&[B?@5TT/4R,TUVDT^<Z<['[HSEMZZR
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M-=Z;W@CLAA'])*6/IISW2N9"VYT^8FC`<S74D=9.1J`[YI.;J`3ODE:5+&W:
MQ<>'P/`[VW>/,Z;4?;*LMDEB]ZTGJGH?O.8^E.\26.IL%/EV2&WR7*6Y2W!L
MM.:>&6**5L=`X=^F8\\"T8[.^0JB]A2LX*HJCDL<,,/.>X[N7%WG]R[1VT:,
ME#B<F\5@FD\(Z\=.CD/T!ME#!:;;06NG>Y\%OI8J6-\I;SDC8FX%[]G0'/<2
M<!J7FYR<YRF];9]>MZ,;:A1MX-N$(I+$OL1OCC"U.PQ&^.,(!B-\<80#$;XX
MP@&(WQQA`,1OCC"`8C?'&$`Q&^.,(!B-\<80#$;XXP@&(WQQA`,1OCC"`8C?
M'&$`Q&^.,(!B-\<80#$;XXP@&(WQQA`1UPO5DM$9FN]ZM%IB:W:+[E<J2C['
M?#)Y62.'4!Q6T83F\(0E)\R;.-:YM;9.5S=4Z<?VI)>5XFJ[S^H#HLM!?'!?
MGWZH;B.:L=.Z>(N&YWY4&"F`QW<2%-IY;>3TNGPKG?F//77?'(+;%0NW6GLI
MK%>L\$:GO/ZH9I`YF7LO4%*-.Q4WFX"JD&\324ABBQX#(5,IY0E]+5;\"ZSS
MEUW_`)/%65C"//.6+W1P726]DS'G_I(MLMRKND"ILMM[\GHO%V7:>GH'.,+6
M.>XU$1:X-<),!BYQ6M:-M9S5.-LI3PQQD\3IEU;.N\-M*ZK9S*E;\;CPTHJ.
MK#E7AT:R_INCC)\<G?%PAJ+_`%9TNJK[<)J]SG;YC?((AIX%RE?7#6$&H1V)
M8%A2[MY3"7'6HRKU=M23ET:C/GV.Q5$4>S3Q0AL;&-=2R\SLAC`T-`!+>QPP
MTA1U.:U/$N96-I.*2I):.308_<LM04E+4U=/7XMIHG3.BF#,2QN&($C"WLM.
MZ%TC4;:3CK(-QET:5.I5A5>$5C@^LPT30D8\['I]6WKKL5.*VCGH?=8^6WKH
M,5M.#)`[7)$>$O9B.H<<0@T,DJ._7"W$=XW>HIP-(8VJVHO>I'/9AP8+64(2
M[44SO2NKBCA[*O)+9CHW&64?23=8,&U?B^O:,,7.PII2,=)VX7;!)&^U<96T
M'V<46-+.[J."JQA-;GT&54?278IL&UL510N.M[71U4(/"8RV0#UJXRMIKLM,
MGT\\M9:*M.4'O1EM%F6PW!NQ1WJW3AV@P25,4;CB-3H*@MQXBN4J52/:@RRI
M7MI76%*Y@T^1O#H9$W;).2[[B^XY?M,DKA\*IHVT=3B?VQ/1NB+CNXZ5O"XK
MT^Q5>&S6B-<91E=WBZ]C3<GRI<+WK`UO=.@K+E1M.M%YN-K<>UBJ>:N-.W@)
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M05]14SNDEN$3*:J=`'-%/[?^^9%LZ6@`8JGNZT95<%4Q@ER=)[S(<MN(6:G.
MTX*TI-XR6#PY->G#8;-BL#G8&IK&`Z.QB[,]0O>0/.*A>T7(CT4;"3:=2KNT
M^4DHK-;(^V;SYUXS28CDMV6K7CEM)$+.WCKAQ/G)2-L$0V8FPQ`;D;6-\\:2
MM23%*/9BEX#OMM].WE#KH9&VSTS>4.N@&VSTS>4.N@.['-Q[9NK?'`@*NVST
MS>4.N@&VSTS>4.N@&VSTS>,==`2-LE_ZC8$G8EKB6[6@D#0<,<,0@,@Q&^.,
M(!B-\<80#$;XXP@&(WQQA`?_U_OV?VCNT[4]OVGKO4H"Q\GH!Y/0#R>@.AUG
MYKU[NOS>%`<>2T`\EH!Y+0#R6@'DM`/):`>2T`\EH#LW7_AOK=:PP4)^V'S-
MJ_C]MYG`MEXS2>OT?&4/P^L[S3U!^'TWCU!^'TWCU!^'TWCU!^'TWCU!^'TW
MCU!^'TWCU!^'TWCU!^'TWCU!^'TWCU!^'TWCU!^'TWCU"G+VH^S?;?Q>UU'5
MZI97+VC66K^'XRA^%%GUCG]B/PHGK#[$?A1/6'V)CU1[?+_VS]L=\(]OU_Q?
M]YOKK'4OI/$19]N?W37RZ_'SE'_]6K/VIK_Z9?47;._[=[GP+MO7+67_`,GC
M-Z>O_P"KXB;M_P`)D^RWM3OF_P"$]LWVS_=;_#@N<M7I>,DT/I']#J]'7_D3
M/D]<R8/)Z`>3T`\GH!Y/0#R>@'D]`/)Z`>3T`\GH!Y/0#R>@'D]`/)Z`>3T`
M\GH!Y/0#R>@,?O/MD?V/U#YY]LUGVO@76'+VO$0[KM+Z'_7K+,:A]@]6YJ\S
M@6?7./(ONQS^!$]<?^L2=)[2?LOV[O@GM.H:_5[ZTEKY?&2:/8_AZ_1U?YEU
MY!6N\Z^J=VZO\$];J0RO$</[1WS'J/;]IZ[@0/4]19?A9;;SE]F/PLF\?9C\
M+)O'V8_"R;Q]F/PLF\?9C\+)O'V9T/;M^R>YK[?7^RG)Z1J]?\(F!J'S7J&K
M5JW.!:$H>2T`\EH#M5?!'_-O:GX5\$W>W]2LK6*GT;\^HQG\#KMZY!^P'X'3
MUQ]@7]N^$C[+=J?F[X3K&KU*TGJ]+QG:AV_X?^G63,O;_P"'ZA[;V^KT%S1)
MEKZRGY+0P/):`>2T`\EH!Y+0#R6@'DM`/):`>2T`\EH#LW7_`(9ZW6@.WD]`
+/)Z`>3T`\GH#_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
